Gene Symbol | Gene ID | Gene Info |
---|---|---|
Mecp2
|
ENSMUSG00000031393.10 | methyl CpG binding protein 2 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chrX_74084945_74085536 | Mecp2 | 357 | 0.802554 | 0.67 | 2.9e-08 | Click! |
chrX_74085608_74086008 | Mecp2 | 118 | 0.942238 | 0.57 | 5.0e-06 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr3_94477953_94478530 | 12.53 |
Celf3 |
CUGBP, Elav-like family member 3 |
54 |
0.93 |
chr7_67372280_67373557 | 12.00 |
Mef2a |
myocyte enhancer factor 2A |
60 |
0.97 |
chr1_55405664_55406438 | 11.58 |
Plcl1 |
phospholipase C-like 1 |
130 |
0.95 |
chr13_13783865_13785053 | 11.40 |
Gng4 |
guanine nucleotide binding protein (G protein), gamma 4 |
130 |
0.96 |
chr15_39197089_39197893 | 11.37 |
Rims2 |
regulating synaptic membrane exocytosis 2 |
770 |
0.61 |
chr3_93446951_93447770 | 11.12 |
Tchh |
trichohyalin |
5030 |
0.1 |
chr13_101767322_101768046 | 10.67 |
Pik3r1 |
phosphoinositide-3-kinase regulatory subunit 1 |
529 |
0.8 |
chr11_102393202_102394154 | 10.47 |
Rundc3a |
RUN domain containing 3A |
275 |
0.82 |
chr3_79286472_79287715 | 10.38 |
6430573P05Rik |
RIKEN cDNA 6430573P05 gene |
80 |
0.9 |
chr19_30174880_30175317 | 10.27 |
Gldc |
glycine decarboxylase |
331 |
0.89 |
chr7_84605702_84606753 | 9.69 |
Fah |
fumarylacetoacetate hydrolase |
285 |
0.89 |
chr15_39198217_39199017 | 9.50 |
Rims2 |
regulating synaptic membrane exocytosis 2 |
254 |
0.91 |
chr17_8800581_8801529 | 9.40 |
Pde10a |
phosphodiesterase 10A |
638 |
0.79 |
chr7_79535477_79536145 | 9.35 |
Gm35040 |
predicted gene, 35040 |
232 |
0.85 |
chr18_64265188_64265726 | 9.32 |
St8sia3 |
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 3 |
529 |
0.73 |
chr3_125937638_125938666 | 9.09 |
Ugt8a |
UDP galactosyltransferase 8A |
399 |
0.92 |
chr6_17693827_17694982 | 9.05 |
St7 |
suppression of tumorigenicity 7 |
237 |
0.9 |
chr2_116975074_116976384 | 8.81 |
Gm29340 |
predicted gene 29340 |
699 |
0.69 |
chr15_38470164_38471480 | 8.79 |
G930009F23Rik |
RIKEN cDNA G930009F23 gene |
15688 |
0.13 |
chr1_173367143_173367780 | 8.61 |
Cadm3 |
cell adhesion molecule 3 |
172 |
0.94 |
chr3_93446427_93446907 | 8.52 |
Tchh |
trichohyalin |
4337 |
0.1 |
chr13_54948652_54949299 | 8.49 |
Unc5a |
unc-5 netrin receptor A |
436 |
0.79 |
chr11_94327762_94328694 | 8.44 |
Ankrd40 |
ankyrin repeat domain 40 |
26 |
0.97 |
chr3_158561021_158562021 | 8.25 |
Lrrc7 |
leucine rich repeat containing 7 |
176 |
0.97 |
chr4_19569392_19570378 | 8.03 |
Cpne3 |
copine III |
198 |
0.94 |
chr1_175492264_175493051 | 8.02 |
Rgs7 |
regulator of G protein signaling 7 |
157 |
0.97 |
chr4_136835920_136836937 | 7.94 |
Ephb2 |
Eph receptor B2 |
440 |
0.83 |
chr10_81559146_81561402 | 7.92 |
Tle5 |
TLE family member 5, transcriptional modulator |
770 |
0.38 |
chr12_49401253_49401829 | 7.89 |
Gm48659 |
predicted gene, 48659 |
10707 |
0.13 |
chr1_34011060_34011688 | 7.85 |
Dst |
dystonin |
439 |
0.79 |
chr18_25678986_25679896 | 7.84 |
0710001A04Rik |
RIKEN cDNA 0710001A04 gene |
34329 |
0.19 |
chr15_41446975_41448253 | 7.84 |
Oxr1 |
oxidation resistance 1 |
132 |
0.98 |
chr8_81014564_81015028 | 7.80 |
Usp38 |
ubiquitin specific peptidase 38 |
117 |
0.78 |
chr3_10439292_10440192 | 7.77 |
Snx16 |
sorting nexin 16 |
345 |
0.89 |
chr7_57590461_57591180 | 7.72 |
Gabrb3 |
gamma-aminobutyric acid (GABA) A receptor, subunit beta 3 |
302 |
0.92 |
chr19_53037917_53038483 | 7.70 |
Xpnpep1 |
X-prolyl aminopeptidase (aminopeptidase P) 1, soluble |
353 |
0.86 |
chr7_4119309_4120004 | 7.64 |
Ttyh1 |
tweety family member 1 |
34 |
0.91 |
chr14_39473001_39473750 | 7.63 |
Nrg3 |
neuregulin 3 |
287 |
0.95 |
chr1_131097316_131097969 | 7.60 |
Mapkapk2 |
MAP kinase-activated protein kinase 2 |
184 |
0.92 |
chr11_32220828_32222435 | 7.57 |
Rhbdf1 |
rhomboid 5 homolog 1 |
613 |
0.58 |
chr15_64311804_64313067 | 7.52 |
Asap1 |
ArfGAP with SH3 domain, ankyrin repeat and PH domain1 |
204 |
0.93 |
chr7_38106770_38108111 | 7.50 |
Ccne1 |
cyclin E1 |
62 |
0.97 |
chr14_34819764_34820558 | 7.50 |
Grid1 |
glutamate receptor, ionotropic, delta 1 |
53 |
0.98 |
chr15_36282355_36283194 | 7.46 |
Rnf19a |
ring finger protein 19A |
324 |
0.83 |
chr2_54435866_54436297 | 7.45 |
Galnt13 |
polypeptide N-acetylgalactosaminyltransferase 13 |
236 |
0.96 |
chr11_20740804_20741510 | 7.40 |
Aftph |
aftiphilin |
298 |
0.9 |
chr1_179802885_179803540 | 7.39 |
Gm10518 |
predicted gene 10518 |
164 |
0.76 |
chr12_102948773_102949716 | 7.31 |
Unc79 |
unc-79 homolog |
310 |
0.88 |
chr1_22806069_22806442 | 7.30 |
Rims1 |
regulating synaptic membrane exocytosis 1 |
261 |
0.95 |
chr6_113195212_113195613 | 7.19 |
Lhfpl4 |
lipoma HMGIC fusion partner-like protein 4 |
28 |
0.97 |
chr14_111675429_111676589 | 7.18 |
Slitrk5 |
SLIT and NTRK-like family, member 5 |
160 |
0.96 |
chr5_72647648_72648602 | 7.17 |
Nipal1 |
NIPA-like domain containing 1 |
283 |
0.84 |
chr14_103650552_103650802 | 7.15 |
Slain1 |
SLAIN motif family, member 1 |
31 |
0.6 |
chr13_78163091_78163982 | 7.08 |
3110006O06Rik |
RIKEN cDNA 3110006O06 gene |
8094 |
0.14 |
chr3_107630969_107631561 | 7.04 |
Gm10961 |
predicted gene 10961 |
57 |
0.86 |
chr12_112721309_112722969 | 7.04 |
Cep170b |
centrosomal protein 170B |
35 |
0.95 |
chr10_13964562_13965238 | 7.02 |
Hivep2 |
human immunodeficiency virus type I enhancer binding protein 2 |
1175 |
0.49 |
chr2_102451171_102452295 | 6.99 |
Fjx1 |
four jointed box 1 |
766 |
0.72 |
chr4_24966254_24966983 | 6.96 |
C230012O17Rik |
RIKEN cDNA C230012O17 gene |
2 |
0.49 |
chr6_24955463_24956619 | 6.93 |
Tmem229a |
transmembrane protein 229A |
256 |
0.93 |
chr4_109977849_109978740 | 6.89 |
Dmrta2 |
doublesex and mab-3 related transcription factor like family A2 |
241 |
0.73 |
chr4_11155764_11156471 | 6.87 |
Trp53inp1 |
transformation related protein 53 inducible nuclear protein 1 |
314 |
0.83 |
chr3_58576834_58577273 | 6.79 |
Selenot |
selenoprotein T |
355 |
0.85 |
chr10_89685517_89686413 | 6.78 |
Scyl2 |
SCY1-like 2 (S. cerevisiae) |
298 |
0.59 |
chr9_124439906_124440949 | 6.73 |
Ppp2r3d |
protein phosphatase 2 (formerly 2A), regulatory subunit B'', delta |
441 |
0.79 |
chr10_71347966_71348595 | 6.66 |
Ipmk |
inositol polyphosphate multikinase |
437 |
0.76 |
chr6_48085879_48086421 | 6.63 |
Zfp746 |
zinc finger protein 746 |
396 |
0.82 |
chr13_111686492_111687222 | 6.63 |
Mier3 |
MIER family member 3 |
45 |
0.97 |
chr11_49203090_49203797 | 6.62 |
Zfp62 |
zinc finger protein 62 |
42 |
0.96 |
chr3_89773473_89773968 | 6.62 |
Ube2q1 |
ubiquitin-conjugating enzyme E2Q family member 1 |
104 |
0.84 |
chr2_109677143_109677796 | 6.59 |
Bdnf |
brain derived neurotrophic factor |
437 |
0.68 |
chr7_122970081_122970737 | 6.58 |
Rbbp6 |
retinoblastoma binding protein 6, ubiquitin ligase |
155 |
0.73 |
chr3_37419062_37420017 | 6.55 |
Nudt6 |
nudix (nucleoside diphosphate linked moiety X)-type motif 6 |
18 |
0.84 |
chr2_143545715_143546271 | 6.54 |
Pcsk2os1 |
proprotein convertase subtilisin/kexin type 2, opposite strand 1 |
16 |
0.67 |
chr18_25754073_25754459 | 6.49 |
Celf4 |
CUGBP, Elav-like family member 4 |
109 |
0.97 |
chr1_181211919_181212653 | 6.48 |
Wdr26 |
WD repeat domain 26 |
285 |
0.87 |
chr2_23571610_23572204 | 6.48 |
Spopl |
speckle-type BTB/POZ protein-like |
71 |
0.98 |
chr17_74489622_74490192 | 6.47 |
Yipf4 |
Yip1 domain family, member 4 |
29 |
0.97 |
chr1_54925534_54926512 | 6.46 |
Ankrd44 |
ankyrin repeat domain 44 |
331 |
0.88 |
chr19_12501063_12501779 | 6.44 |
Dtx4 |
deltex 4, E3 ubiquitin ligase |
33 |
0.96 |
chr2_174109835_174111101 | 6.44 |
Npepl1 |
aminopeptidase-like 1 |
119 |
0.96 |
chr18_53175929_53176995 | 6.42 |
Snx2 |
sorting nexin 2 |
73 |
0.98 |
chr1_143776711_143777957 | 6.41 |
Uchl5 |
ubiquitin carboxyl-terminal esterase L5 |
13 |
0.68 |
chr5_72558899_72559546 | 6.41 |
Nfxl1 |
nuclear transcription factor, X-box binding-like 1 |
190 |
0.9 |
chr17_52601056_52601789 | 6.39 |
Gm27217 |
predicted gene 27217 |
1238 |
0.39 |
chr19_37550406_37551061 | 6.36 |
Exoc6 |
exocyst complex component 6 |
274 |
0.92 |
chr4_6453881_6454350 | 6.32 |
Nsmaf |
neutral sphingomyelinase (N-SMase) activation associated factor |
18 |
0.98 |
chr7_127614562_127615395 | 6.31 |
Zfp629 |
zinc finger protein 629 |
111 |
0.91 |
chr10_86778157_86779118 | 6.30 |
Nt5dc3 |
5'-nucleotidase domain containing 3 |
368 |
0.78 |
chr6_39557035_39557678 | 6.29 |
Dennd2a |
DENN/MADD domain containing 2A |
511 |
0.7 |
chr1_95313698_95314511 | 6.28 |
Fam174a |
family with sequence similarity 174, member A |
476 |
0.84 |
chr6_55451539_55452374 | 6.28 |
Adcyap1r1 |
adenylate cyclase activating polypeptide 1 receptor 1 |
22 |
0.98 |
chr6_42349301_42350702 | 6.28 |
Zyx |
zyxin |
32 |
0.92 |
chr15_39112167_39112980 | 6.23 |
Slc25a32 |
solute carrier family 25, member 32 |
59 |
0.78 |
chr7_79515104_79515926 | 6.23 |
Mir9-3hg |
Mir9-3 host gene |
80 |
0.92 |
chr9_89210795_89211528 | 6.22 |
Mthfs |
5, 10-methenyltetrahydrofolate synthetase |
4 |
0.97 |
chr11_17158686_17159951 | 6.19 |
Ppp3r1 |
protein phosphatase 3, regulatory subunit B, alpha isoform (calcineurin B, type I) |
55 |
0.97 |
chr10_61146290_61147090 | 6.16 |
Sgpl1 |
sphingosine phosphate lyase 1 |
208 |
0.92 |
chr17_88440728_88441766 | 6.15 |
Foxn2 |
forkhead box N2 |
472 |
0.82 |
chr13_117602607_117603236 | 6.15 |
Hcn1 |
hyperpolarization activated cyclic nucleotide gated potassium channel 1 |
441 |
0.9 |
chr11_6599159_6600158 | 6.13 |
Nacad |
NAC alpha domain containing |
266 |
0.81 |
chr18_38212155_38213063 | 6.12 |
Pcdh1 |
protocadherin 1 |
556 |
0.57 |
chr1_172375985_172377238 | 6.11 |
Pigm |
phosphatidylinositol glycan anchor biosynthesis, class M |
65 |
0.96 |
chr5_14514560_14515558 | 6.11 |
Pclo |
piccolo (presynaptic cytomatrix protein) |
66 |
0.97 |
chr3_36862669_36863444 | 6.09 |
4932438A13Rik |
RIKEN cDNA 4932438A13 gene |
48 |
0.98 |
chr9_92541870_92542582 | 6.07 |
Plod2 |
procollagen lysine, 2-oxoglutarate 5-dioxygenase 2 |
3 |
0.92 |
chr7_55841868_55843022 | 6.03 |
Cyfip1 |
cytoplasmic FMR1 interacting protein 1 |
190 |
0.94 |
chr10_71284478_71285120 | 6.02 |
Ube2d1 |
ubiquitin-conjugating enzyme E2D 1 |
419 |
0.75 |
chr1_161034434_161035250 | 6.01 |
Zbtb37 |
zinc finger and BTB domain containing 37 |
6 |
0.51 |
chr6_4600437_4601751 | 6.00 |
Casd1 |
CAS1 domain containing 1 |
52 |
0.96 |
chr5_39644263_39645259 | 5.98 |
Hs3st1 |
heparan sulfate (glucosamine) 3-O-sulfotransferase 1 |
127 |
0.97 |
chr3_100685357_100686150 | 5.96 |
Man1a2 |
mannosidase, alpha, class 1A, member 2 |
250 |
0.88 |
chr7_98177614_98179153 | 5.95 |
Capn5 |
calpain 5 |
109 |
0.93 |
chr2_151701768_151703133 | 5.94 |
Tmem74b |
transmembrane protein 74B |
139 |
0.92 |
chr18_34860421_34860937 | 5.92 |
Egr1 |
early growth response 1 |
528 |
0.71 |
chr5_20701781_20702802 | 5.91 |
Magi2 |
membrane associated guanylate kinase, WW and PDZ domain containing 2 |
622 |
0.76 |
chr12_44329338_44330111 | 5.90 |
Nrcam |
neuronal cell adhesion molecule |
474 |
0.8 |
chr18_44380653_44381201 | 5.89 |
Dcp2 |
decapping mRNA 2 |
400 |
0.87 |
chr16_30008419_30009386 | 5.89 |
4632428C04Rik |
RIKEN cDNA 4632428C04 gene |
235 |
0.92 |
chr5_89883055_89883755 | 5.89 |
Adamts3 |
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 3 |
71 |
0.98 |
chr4_94602668_94603308 | 5.88 |
Plaa |
phospholipase A2, activating protein |
147 |
0.94 |
chr9_7184636_7184839 | 5.87 |
Dcun1d5 |
DCN1, defective in cullin neddylation 1, domain containing 5 (S. cerevisiae) |
186 |
0.63 |
chr5_146385366_146385636 | 5.86 |
Wasf3 |
WAS protein family, member 3 |
516 |
0.79 |
chr17_69968795_69969671 | 5.85 |
Dlgap1 |
DLG associated protein 1 |
13 |
0.98 |
chr15_6708302_6709258 | 5.82 |
Rictor |
RPTOR independent companion of MTOR, complex 2 |
397 |
0.87 |
chr10_99106993_99107770 | 5.79 |
Poc1b |
POC1 centriolar protein B |
278 |
0.67 |
chr18_63691703_63692290 | 5.79 |
Txnl1 |
thioredoxin-like 1 |
326 |
0.88 |
chr3_84814728_84815427 | 5.78 |
Fbxw7 |
F-box and WD-40 domain protein 7 |
191 |
0.96 |
chr13_9094364_9094777 | 5.77 |
Larp4b |
La ribonucleoprotein domain family, member 4B |
588 |
0.7 |
chrX_74282355_74283413 | 5.76 |
Taz |
tafazzin |
37 |
0.86 |
chr3_139205505_139205701 | 5.76 |
Stpg2 |
sperm tail PG rich repeat containing 2 |
91 |
0.98 |
chr14_72709285_72709892 | 5.75 |
Fndc3a |
fibronectin type III domain containing 3A |
46 |
0.98 |
chr17_35262621_35263779 | 5.74 |
H2-D1 |
histocompatibility 2, D region locus 1 |
104 |
0.88 |
chr6_91284995_91285433 | 5.73 |
Fbln2 |
fibulin 2 |
19335 |
0.17 |
chr12_81332533_81333519 | 5.73 |
Slc8a3 |
solute carrier family 8 (sodium/calcium exchanger), member 3 |
67 |
0.97 |
chr10_106469332_106470360 | 5.71 |
Ppfia2 |
protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 2 |
493 |
0.82 |
chr13_12650037_12651101 | 5.71 |
Gpr137b-ps |
G protein-coupled receptor 137B, pseudogene |
181 |
0.91 |
chr6_140423627_140425006 | 5.70 |
Plekha5 |
pleckstrin homology domain containing, family A member 5 |
155 |
0.96 |
chr13_13393240_13394314 | 5.69 |
Gpr137b |
G protein-coupled receptor 137B |
153 |
0.93 |
chrX_13845780_13846600 | 5.67 |
Cask |
calcium/calmodulin-dependent serine protein kinase (MAGUK family) |
102 |
0.98 |
chr9_74952266_74953620 | 5.66 |
Fam214a |
family with sequence similarity 214, member A |
21 |
0.98 |
chr11_50225498_50225980 | 5.66 |
Mgat4b |
mannoside acetylglucosaminyltransferase 4, isoenzyme B |
404 |
0.73 |
chr3_116807637_116808371 | 5.64 |
Agl |
amylo-1,6-glucosidase, 4-alpha-glucanotransferase |
27 |
0.96 |
chr4_43669111_43669978 | 5.62 |
Tmem8b |
transmembrane protein 8B |
12 |
0.83 |
chr14_54464039_54465014 | 5.61 |
Gm10366 |
predicted gene 10366 |
216 |
0.64 |
chr5_138084988_138085604 | 5.61 |
Zkscan1 |
zinc finger with KRAB and SCAN domains 1 |
176 |
0.88 |
chr8_54529271_54530273 | 5.60 |
Asb5 |
ankyrin repeat and SOCs box-containing 5 |
192 |
0.54 |
chr4_59548682_59549911 | 5.60 |
Ptbp3 |
polypyrimidine tract binding protein 3 |
1 |
0.64 |
chr1_34801592_34802326 | 5.60 |
Arhgef4 |
Rho guanine nucleotide exchange factor (GEF) 4 |
165 |
0.93 |
chr14_14350947_14351733 | 5.59 |
Il3ra |
interleukin 3 receptor, alpha chain |
1719 |
0.23 |
chr15_8443700_8444092 | 5.59 |
Nipbl |
NIPBL cohesin loading factor |
567 |
0.74 |
chr2_149830360_149831343 | 5.59 |
Syndig1 |
synapse differentiation inducing 1 |
8 |
0.86 |
chr2_165511107_165511805 | 5.58 |
Slc2a10 |
solute carrier family 2 (facilitated glucose transporter), member 10 |
2675 |
0.23 |
chr4_21678855_21679292 | 5.57 |
Prdm13 |
PR domain containing 13 |
6708 |
0.18 |
chr19_34878624_34879521 | 5.57 |
Pank1 |
pantothenate kinase 1 |
383 |
0.85 |
chr3_107102135_107102648 | 5.55 |
Kcna2 |
potassium voltage-gated channel, shaker-related subfamily, member 2 |
291 |
0.88 |
chr12_80759665_80760570 | 5.52 |
Ccdc177 |
coiled-coil domain containing 177 |
570 |
0.61 |
chr6_42323997_42324544 | 5.51 |
Fam131b |
family with sequence similarity 131, member B |
322 |
0.78 |
chr1_58972977_58974247 | 5.48 |
Stradb |
STE20-related kinase adaptor beta |
90 |
0.63 |
chr10_21160500_21160889 | 5.48 |
Myb |
myeloblastosis oncogene |
156 |
0.94 |
chr1_172632394_172632933 | 5.47 |
Dusp23 |
dual specificity phosphatase 23 |
299 |
0.86 |
chr9_88719459_88720181 | 5.47 |
Mthfsl |
5, 10-methenyltetrahydrofolate synthetase-like |
7 |
0.7 |
chr17_79614907_79615351 | 5.46 |
Rmdn2 |
regulator of microtubule dynamics 2 |
67 |
0.98 |
chr4_84884464_84885113 | 5.46 |
Cntln |
centlein, centrosomal protein |
323 |
0.91 |
chr16_31274687_31275113 | 5.41 |
Ppp1r2 |
protein phosphatase 1, regulatory inhibitor subunit 2 |
92 |
0.94 |
chr3_108200100_108200985 | 5.40 |
Cyb561d1 |
cytochrome b-561 domain containing 1 |
53 |
0.94 |
chr8_109778777_109779200 | 5.38 |
Ap1g1 |
adaptor protein complex AP-1, gamma 1 subunit |
82 |
0.97 |
chr5_37245988_37246869 | 5.38 |
Crmp1 |
collapsin response mediator protein 1 |
583 |
0.76 |
chrX_142390195_142391160 | 5.38 |
Acsl4 |
acyl-CoA synthetase long-chain family member 4 |
142 |
0.95 |
chr9_22050523_22050944 | 5.36 |
Elavl3 |
ELAV like RNA binding protein 3 |
1277 |
0.23 |
chr15_3978842_3979670 | 5.36 |
Fbxo4 |
F-box protein 4 |
317 |
0.85 |
chr11_80428777_80429451 | 5.35 |
Psmd11 |
proteasome (prosome, macropain) 26S subunit, non-ATPase, 11 |
424 |
0.83 |
chr17_63864110_63864433 | 5.35 |
Fer |
fer (fms/fps related) protein kinase |
256 |
0.71 |
chr3_115887556_115888230 | 5.34 |
A930005H10Rik |
RIKEN cDNA A930005H10 gene |
6 |
0.51 |
chr2_93013668_93015442 | 5.33 |
Prdm11 |
PR domain containing 11 |
645 |
0.73 |
chr2_20968409_20969455 | 5.32 |
Arhgap21 |
Rho GTPase activating protein 21 |
51 |
0.59 |
chr10_121309994_121311399 | 5.32 |
Tbc1d30 |
TBC1 domain family, member 30 |
493 |
0.76 |
chr2_172345010_172346316 | 5.32 |
Fam210b |
family with sequence similarity 210, member B |
98 |
0.95 |
chr10_59615987_59616547 | 5.31 |
Gm10322 |
predicted gene 10322 |
203 |
0.7 |
chr3_31095199_31095600 | 5.30 |
Skil |
SKI-like |
274 |
0.92 |
chr7_45872639_45873973 | 5.28 |
Kdelr1 |
KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 1 |
179 |
0.85 |
chr7_63212002_63212745 | 5.28 |
Chrna7 |
cholinergic receptor, nicotinic, alpha polypeptide 7 |
140 |
0.98 |
chr1_191224278_191225037 | 5.28 |
D730003I15Rik |
RIKEN cDNA D730003I15 gene |
183 |
0.92 |
chrX_42149586_42150039 | 5.27 |
Stag2 |
stromal antigen 2 |
129 |
0.78 |
chr1_85793898_85794116 | 5.27 |
Cab39 |
calcium binding protein 39 |
461 |
0.73 |
chr4_116016940_116018214 | 5.27 |
Faah |
fatty acid amide hydrolase |
98 |
0.95 |
chr3_131490224_131490440 | 5.27 |
Sgms2 |
sphingomyelin synthase 2 |
147 |
0.97 |
chr14_105258890_105259323 | 5.26 |
Ndfip2 |
Nedd4 family interacting protein 2 |
288 |
0.88 |
chr1_84284518_84285108 | 5.25 |
Pid1 |
phosphotyrosine interaction domain containing 1 |
168 |
0.97 |
chr14_73552509_73553339 | 5.23 |
Sucla2 |
succinate-Coenzyme A ligase, ADP-forming, beta subunit |
158 |
0.95 |
chr6_135197794_135198561 | 5.23 |
Fam234b |
family with sequence similarity 234, member B |
68 |
0.61 |
chr7_79535266_79535447 | 5.21 |
Gm35040 |
predicted gene, 35040 |
687 |
0.49 |
chr3_138742383_138742585 | 5.21 |
Tspan5 |
tetraspanin 5 |
21 |
0.98 |
chr16_55894641_55895287 | 5.20 |
Nxpe3 |
neurexophilin and PC-esterase domain family, member 3 |
321 |
0.84 |
chr15_89499752_89500815 | 5.19 |
Shank3 |
SH3 and multiple ankyrin repeat domains 3 |
160 |
0.9 |
chr9_55326917_55327533 | 5.19 |
Tmem266 |
transmembrane protein 266 |
276 |
0.6 |
chr1_52726373_52727465 | 5.18 |
Mfsd6 |
major facilitator superfamily domain containing 6 |
439 |
0.8 |
chr7_44310178_44311500 | 5.18 |
Shank1 |
SH3 and multiple ankyrin repeat domains 1 |
586 |
0.43 |
chr8_60632618_60633598 | 5.18 |
Mfap3l |
microfibrillar-associated protein 3-like |
248 |
0.63 |
chr8_75213579_75213989 | 5.17 |
Rasd2 |
RASD family, member 2 |
160 |
0.94 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.8 | 33.8 | GO:0061669 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
5.2 | 15.5 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
4.9 | 14.7 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
4.8 | 19.3 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
4.5 | 13.6 | GO:1990034 | calcium ion export from cell(GO:1990034) |
4.5 | 13.5 | GO:0021986 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
4.3 | 12.9 | GO:0070375 | ERK5 cascade(GO:0070375) |
4.2 | 8.5 | GO:1990035 | calcium ion import into cell(GO:1990035) |
4.2 | 12.5 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
4.0 | 12.0 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
4.0 | 4.0 | GO:0009212 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
4.0 | 11.9 | GO:0046208 | spermine catabolic process(GO:0046208) |
4.0 | 11.9 | GO:0044337 | canonical Wnt signaling pathway involved in positive regulation of apoptotic process(GO:0044337) |
3.9 | 11.7 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
3.9 | 11.6 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
3.8 | 3.8 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
3.7 | 14.8 | GO:0035983 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
3.6 | 3.6 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
3.6 | 10.9 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
3.6 | 10.7 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
3.5 | 14.0 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
3.5 | 10.4 | GO:0090296 | regulation of mitochondrial DNA replication(GO:0090296) |
3.4 | 10.3 | GO:0021553 | olfactory nerve development(GO:0021553) |
3.4 | 10.3 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
3.4 | 3.4 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) |
3.4 | 10.2 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
3.4 | 6.8 | GO:0006538 | glutamate catabolic process(GO:0006538) |
3.4 | 10.1 | GO:0021747 | cochlear nucleus development(GO:0021747) |
3.4 | 10.1 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
3.4 | 13.4 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
3.3 | 6.6 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
3.2 | 9.7 | GO:0006106 | fumarate metabolic process(GO:0006106) |
3.2 | 6.3 | GO:0072235 | distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) |
3.2 | 9.5 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
3.1 | 9.4 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
3.0 | 12.2 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
3.0 | 3.0 | GO:1902946 | protein localization to early endosome(GO:1902946) |
3.0 | 6.0 | GO:0086064 | cell communication by electrical coupling involved in cardiac conduction(GO:0086064) |
3.0 | 8.9 | GO:0061091 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
3.0 | 3.0 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
2.9 | 5.9 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
2.9 | 11.6 | GO:0060486 | Clara cell differentiation(GO:0060486) |
2.8 | 8.5 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
2.8 | 2.8 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
2.8 | 8.3 | GO:0019086 | late viral transcription(GO:0019086) |
2.8 | 8.3 | GO:0061010 | gall bladder development(GO:0061010) |
2.8 | 5.5 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
2.8 | 8.3 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
2.7 | 8.2 | GO:0071873 | response to norepinephrine(GO:0071873) |
2.7 | 10.8 | GO:0034214 | protein hexamerization(GO:0034214) |
2.7 | 10.7 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
2.7 | 10.6 | GO:0003383 | apical constriction(GO:0003383) |
2.6 | 7.9 | GO:0030242 | pexophagy(GO:0030242) |
2.6 | 10.4 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
2.6 | 7.8 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
2.6 | 7.8 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
2.6 | 7.8 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
2.6 | 12.9 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
2.6 | 10.3 | GO:0051581 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
2.6 | 7.7 | GO:2000437 | monocyte extravasation(GO:0035696) regulation of monocyte extravasation(GO:2000437) |
2.6 | 20.4 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
2.5 | 12.6 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
2.5 | 20.1 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
2.5 | 2.5 | GO:0090188 | negative regulation of pancreatic juice secretion(GO:0090188) |
2.5 | 12.5 | GO:0021764 | amygdala development(GO:0021764) |
2.5 | 9.8 | GO:0010612 | regulation of cardiac muscle adaptation(GO:0010612) regulation of cardiac muscle hypertrophy in response to stress(GO:1903242) |
2.4 | 12.2 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
2.4 | 4.9 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
2.4 | 9.7 | GO:0046881 | positive regulation of gonadotropin secretion(GO:0032278) positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
2.4 | 9.7 | GO:0007412 | axon target recognition(GO:0007412) |
2.4 | 7.1 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
2.4 | 11.9 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
2.4 | 14.1 | GO:0090527 | actin filament reorganization(GO:0090527) |
2.3 | 4.7 | GO:0051586 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
2.3 | 7.0 | GO:1901660 | calcium ion export(GO:1901660) |
2.3 | 7.0 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
2.3 | 14.0 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
2.3 | 7.0 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
2.3 | 6.9 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
2.3 | 4.6 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
2.3 | 22.9 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
2.3 | 6.9 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
2.3 | 6.8 | GO:0015888 | thiamine transport(GO:0015888) |
2.3 | 6.8 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
2.3 | 13.6 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
2.3 | 2.3 | GO:0048880 | sensory system development(GO:0048880) |
2.2 | 6.7 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
2.2 | 9.0 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
2.2 | 9.0 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
2.2 | 8.9 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
2.2 | 6.7 | GO:1903416 | response to glycoside(GO:1903416) |
2.2 | 4.4 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
2.2 | 15.6 | GO:0001547 | antral ovarian follicle growth(GO:0001547) |
2.2 | 6.6 | GO:0070103 | regulation of interleukin-6-mediated signaling pathway(GO:0070103) |
2.2 | 6.6 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
2.2 | 6.6 | GO:0034093 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
2.2 | 2.2 | GO:1900451 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
2.2 | 6.6 | GO:0002913 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
2.2 | 6.6 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
2.2 | 2.2 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
2.2 | 17.3 | GO:0071420 | cellular response to histamine(GO:0071420) |
2.2 | 4.3 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
2.1 | 8.6 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
2.1 | 8.6 | GO:0045829 | negative regulation of isotype switching(GO:0045829) |
2.1 | 12.8 | GO:0048102 | autophagic cell death(GO:0048102) |
2.1 | 6.4 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
2.1 | 6.4 | GO:0032377 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
2.1 | 6.3 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
2.1 | 2.1 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
2.1 | 16.8 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
2.1 | 10.5 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
2.1 | 6.3 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
2.1 | 4.2 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
2.1 | 16.6 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
2.1 | 6.2 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
2.1 | 10.3 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
2.1 | 10.3 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
2.1 | 16.5 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
2.1 | 8.2 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
2.0 | 4.1 | GO:0051256 | mitotic spindle elongation(GO:0000022) mitotic spindle midzone assembly(GO:0051256) |
2.0 | 6.1 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
2.0 | 6.1 | GO:0030070 | insulin processing(GO:0030070) |
2.0 | 12.2 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
2.0 | 6.1 | GO:0006553 | lysine metabolic process(GO:0006553) |
2.0 | 6.1 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
2.0 | 8.1 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
2.0 | 6.1 | GO:1901656 | glycoside transport(GO:1901656) |
2.0 | 2.0 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
2.0 | 8.0 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
2.0 | 6.0 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
2.0 | 4.0 | GO:0035262 | gonad morphogenesis(GO:0035262) |
2.0 | 14.0 | GO:1900103 | positive regulation of endoplasmic reticulum unfolded protein response(GO:1900103) |
2.0 | 4.0 | GO:0052203 | modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
2.0 | 6.0 | GO:1904220 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
2.0 | 2.0 | GO:0045794 | negative regulation of cell volume(GO:0045794) |
2.0 | 4.0 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
2.0 | 9.9 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
2.0 | 17.8 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
2.0 | 3.9 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
2.0 | 5.9 | GO:1990123 | L-glutamate(1-) import into cell(GO:1903802) L-glutamate import into cell(GO:1990123) |
2.0 | 5.9 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
2.0 | 9.8 | GO:0033762 | response to glucagon(GO:0033762) |
2.0 | 3.9 | GO:2000138 | positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
2.0 | 5.9 | GO:0051182 | coenzyme transport(GO:0051182) |
1.9 | 5.8 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
1.9 | 3.9 | GO:0072718 | response to cisplatin(GO:0072718) |
1.9 | 7.8 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
1.9 | 3.9 | GO:0034182 | regulation of maintenance of sister chromatid cohesion(GO:0034091) regulation of maintenance of mitotic sister chromatid cohesion(GO:0034182) |
1.9 | 3.9 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
1.9 | 1.9 | GO:1904587 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
1.9 | 7.7 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
1.9 | 5.7 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
1.9 | 11.5 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
1.9 | 5.7 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
1.9 | 7.6 | GO:0072300 | positive regulation of metanephric glomerulus development(GO:0072300) |
1.9 | 7.6 | GO:0046959 | habituation(GO:0046959) |
1.9 | 1.9 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
1.9 | 43.4 | GO:0006491 | N-glycan processing(GO:0006491) |
1.9 | 7.5 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
1.9 | 3.7 | GO:0071879 | positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
1.9 | 3.7 | GO:0051095 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
1.9 | 11.2 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
1.9 | 3.7 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
1.9 | 3.7 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
1.8 | 5.5 | GO:1990928 | response to amino acid starvation(GO:1990928) |
1.8 | 1.8 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
1.8 | 9.2 | GO:1902373 | negative regulation of mRNA catabolic process(GO:1902373) |
1.8 | 10.9 | GO:0008090 | retrograde axonal transport(GO:0008090) |
1.8 | 12.7 | GO:0021999 | neural plate anterior/posterior regionalization(GO:0021999) |
1.8 | 1.8 | GO:0036260 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
1.8 | 9.0 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
1.8 | 10.7 | GO:0046654 | tetrahydrofolate biosynthetic process(GO:0046654) |
1.8 | 3.6 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
1.8 | 8.9 | GO:0051013 | microtubule severing(GO:0051013) |
1.8 | 1.8 | GO:0086066 | atrial cardiac muscle cell action potential(GO:0086014) atrial cardiac muscle cell to AV node cell signaling(GO:0086026) atrial cardiac muscle cell to AV node cell communication(GO:0086066) |
1.8 | 5.3 | GO:0019896 | axonal transport of mitochondrion(GO:0019896) |
1.8 | 8.8 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
1.8 | 1.8 | GO:0003340 | negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003340) |
1.8 | 3.5 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
1.8 | 8.8 | GO:0015780 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
1.7 | 24.3 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
1.7 | 3.5 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
1.7 | 6.9 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
1.7 | 5.2 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
1.7 | 5.2 | GO:1903894 | regulation of IRE1-mediated unfolded protein response(GO:1903894) |
1.7 | 6.8 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
1.7 | 13.7 | GO:0046069 | cGMP catabolic process(GO:0046069) |
1.7 | 6.8 | GO:0021892 | cerebral cortex GABAergic interneuron differentiation(GO:0021892) |
1.7 | 1.7 | GO:0061590 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
1.7 | 5.1 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
1.7 | 3.4 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
1.7 | 5.1 | GO:0035973 | aggrephagy(GO:0035973) |
1.7 | 10.2 | GO:0070092 | regulation of glucagon secretion(GO:0070092) |
1.7 | 8.4 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
1.7 | 3.4 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
1.7 | 10.1 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
1.7 | 6.7 | GO:0040009 | regulation of growth rate(GO:0040009) |
1.7 | 15.1 | GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway(GO:0010642) |
1.7 | 6.7 | GO:2001168 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
1.7 | 1.7 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
1.7 | 5.0 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
1.7 | 1.7 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
1.7 | 5.0 | GO:0016479 | negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
1.7 | 3.3 | GO:0070669 | response to interleukin-2(GO:0070669) |
1.7 | 1.7 | GO:0002071 | glandular epithelial cell maturation(GO:0002071) |
1.7 | 9.9 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
1.6 | 4.9 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
1.6 | 4.9 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
1.6 | 4.9 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
1.6 | 9.8 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
1.6 | 8.2 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
1.6 | 1.6 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
1.6 | 6.5 | GO:0070842 | aggresome assembly(GO:0070842) |
1.6 | 14.5 | GO:0060546 | negative regulation of necroptotic process(GO:0060546) |
1.6 | 3.2 | GO:0051665 | membrane raft localization(GO:0051665) |
1.6 | 4.8 | GO:0071492 | cellular response to UV-A(GO:0071492) |
1.6 | 6.4 | GO:0098597 | vocal learning(GO:0042297) imitative learning(GO:0098596) observational learning(GO:0098597) learned vocalization behavior or vocal learning(GO:0098598) |
1.6 | 4.8 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
1.6 | 6.3 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
1.6 | 6.3 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
1.6 | 25.4 | GO:1902591 | single-organism membrane budding(GO:1902591) |
1.6 | 9.5 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
1.6 | 9.5 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
1.6 | 3.2 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
1.6 | 6.3 | GO:0071494 | cellular response to UV-C(GO:0071494) |
1.6 | 9.5 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
1.6 | 4.7 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
1.6 | 4.7 | GO:0090148 | membrane fission(GO:0090148) |
1.6 | 7.8 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
1.6 | 12.4 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
1.6 | 6.2 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
1.5 | 1.5 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
1.5 | 3.1 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) regulation of ventricular cardiac muscle cell action potential(GO:0098911) |
1.5 | 10.8 | GO:0034626 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
1.5 | 4.6 | GO:0006046 | N-acetylglucosamine catabolic process(GO:0006046) |
1.5 | 7.6 | GO:0030259 | lipid glycosylation(GO:0030259) |
1.5 | 4.6 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
1.5 | 7.6 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
1.5 | 12.1 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
1.5 | 13.5 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
1.5 | 3.0 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
1.5 | 3.0 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
1.5 | 3.0 | GO:1902065 | response to L-glutamate(GO:1902065) |
1.5 | 6.0 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
1.5 | 3.0 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
1.5 | 6.0 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
1.5 | 4.5 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
1.5 | 3.0 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
1.5 | 8.9 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
1.5 | 10.3 | GO:1904152 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) regulation of retrograde protein transport, ER to cytosol(GO:1904152) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
1.5 | 2.9 | GO:0007386 | compartment pattern specification(GO:0007386) |
1.5 | 1.5 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
1.5 | 5.9 | GO:0023041 | neuronal signal transduction(GO:0023041) |
1.5 | 1.5 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
1.5 | 2.9 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
1.5 | 2.9 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
1.5 | 11.6 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
1.4 | 8.7 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
1.4 | 2.9 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
1.4 | 5.8 | GO:0018317 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
1.4 | 4.3 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
1.4 | 4.3 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
1.4 | 11.5 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
1.4 | 2.9 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
1.4 | 5.7 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
1.4 | 12.9 | GO:0010842 | retina layer formation(GO:0010842) |
1.4 | 11.5 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
1.4 | 1.4 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
1.4 | 4.3 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
1.4 | 11.5 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
1.4 | 10.0 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
1.4 | 2.8 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
1.4 | 17.1 | GO:0070841 | inclusion body assembly(GO:0070841) |
1.4 | 4.3 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
1.4 | 5.7 | GO:0008228 | opsonization(GO:0008228) |
1.4 | 2.8 | GO:1900620 | acetylcholine biosynthetic process(GO:0008292) acetate ester biosynthetic process(GO:1900620) |
1.4 | 43.8 | GO:0007628 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
1.4 | 1.4 | GO:0071877 | regulation of adrenergic receptor signaling pathway(GO:0071877) |
1.4 | 1.4 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
1.4 | 1.4 | GO:0002477 | antigen processing and presentation of exogenous peptide antigen via MHC class Ib(GO:0002477) antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent(GO:0002481) |
1.4 | 4.2 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
1.4 | 5.6 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
1.4 | 2.8 | GO:0032898 | neurotrophin production(GO:0032898) |
1.4 | 2.8 | GO:0006868 | glutamine transport(GO:0006868) |
1.4 | 2.8 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
1.4 | 2.8 | GO:1902221 | L-phenylalanine metabolic process(GO:0006558) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) |
1.4 | 1.4 | GO:0061642 | chemoattraction of axon(GO:0061642) |
1.4 | 4.2 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
1.4 | 4.2 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
1.4 | 1.4 | GO:2000698 | positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) |
1.4 | 11.1 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
1.4 | 1.4 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
1.4 | 5.5 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
1.4 | 5.5 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
1.4 | 13.6 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
1.4 | 8.1 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
1.4 | 5.4 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
1.4 | 17.6 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
1.3 | 6.7 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
1.3 | 6.7 | GO:0035280 | miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
1.3 | 4.0 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
1.3 | 4.0 | GO:0010587 | miRNA catabolic process(GO:0010587) |
1.3 | 1.3 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
1.3 | 1.3 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
1.3 | 9.2 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
1.3 | 15.7 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
1.3 | 2.6 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
1.3 | 22.3 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
1.3 | 7.8 | GO:0045332 | phospholipid translocation(GO:0045332) |
1.3 | 11.7 | GO:0002934 | desmosome organization(GO:0002934) |
1.3 | 20.8 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
1.3 | 3.9 | GO:1900040 | regulation of interleukin-2 secretion(GO:1900040) negative regulation of interleukin-2 secretion(GO:1900041) |
1.3 | 1.3 | GO:0014738 | regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
1.3 | 3.9 | GO:0036258 | multivesicular body assembly(GO:0036258) |
1.3 | 12.8 | GO:0032239 | regulation of nucleobase-containing compound transport(GO:0032239) |
1.3 | 1.3 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
1.3 | 3.8 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
1.3 | 3.8 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
1.3 | 7.7 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
1.3 | 2.5 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
1.3 | 2.5 | GO:2000015 | regulation of determination of dorsal identity(GO:2000015) |
1.3 | 17.8 | GO:0006376 | mRNA splice site selection(GO:0006376) |
1.3 | 2.5 | GO:0001828 | inner cell mass cellular morphogenesis(GO:0001828) |
1.3 | 3.8 | GO:1901503 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
1.3 | 3.8 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
1.3 | 12.7 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
1.3 | 3.8 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
1.3 | 3.8 | GO:0048069 | eye pigmentation(GO:0048069) |
1.3 | 8.8 | GO:0021756 | striatum development(GO:0021756) |
1.3 | 7.5 | GO:0051409 | response to nitrosative stress(GO:0051409) |
1.3 | 7.5 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
1.3 | 2.5 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
1.2 | 6.2 | GO:0006528 | asparagine metabolic process(GO:0006528) |
1.2 | 8.7 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
1.2 | 2.5 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
1.2 | 1.2 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
1.2 | 9.9 | GO:1901160 | primary amino compound metabolic process(GO:1901160) |
1.2 | 8.6 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
1.2 | 1.2 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
1.2 | 2.5 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
1.2 | 3.7 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
1.2 | 3.7 | GO:0060988 | lipid tube assembly(GO:0060988) |
1.2 | 3.7 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
1.2 | 23.3 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
1.2 | 13.5 | GO:0031297 | replication fork processing(GO:0031297) |
1.2 | 2.4 | GO:0035553 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
1.2 | 2.4 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
1.2 | 2.4 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
1.2 | 3.6 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
1.2 | 6.0 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
1.2 | 3.6 | GO:0046104 | thymidine metabolic process(GO:0046104) |
1.2 | 7.2 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
1.2 | 13.2 | GO:0099601 | regulation of neurotransmitter receptor activity(GO:0099601) |
1.2 | 3.6 | GO:1903660 | regulation of complement-dependent cytotoxicity(GO:1903659) negative regulation of complement-dependent cytotoxicity(GO:1903660) |
1.2 | 2.4 | GO:0046958 | nonassociative learning(GO:0046958) |
1.2 | 4.8 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
1.2 | 9.5 | GO:0051561 | positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
1.2 | 9.5 | GO:0016486 | peptide hormone processing(GO:0016486) |
1.2 | 1.2 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
1.2 | 1.2 | GO:0045988 | negative regulation of striated muscle contraction(GO:0045988) |
1.2 | 3.6 | GO:1902608 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
1.2 | 3.5 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
1.2 | 3.5 | GO:0030035 | microspike assembly(GO:0030035) |
1.2 | 2.4 | GO:0070071 | proton-transporting V-type ATPase complex assembly(GO:0070070) proton-transporting two-sector ATPase complex assembly(GO:0070071) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
1.2 | 8.2 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
1.2 | 15.3 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
1.2 | 7.0 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
1.2 | 3.5 | GO:0098787 | mRNA cleavage involved in mRNA processing(GO:0098787) pre-mRNA cleavage required for polyadenylation(GO:0098789) |
1.2 | 14.1 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
1.2 | 1.2 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
1.2 | 3.5 | GO:0048682 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
1.2 | 3.5 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
1.2 | 1.2 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
1.2 | 4.7 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
1.2 | 2.3 | GO:0007529 | establishment of synaptic specificity at neuromuscular junction(GO:0007529) |
1.2 | 3.5 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
1.2 | 24.3 | GO:0043171 | peptide catabolic process(GO:0043171) |
1.2 | 2.3 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
1.2 | 2.3 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
1.2 | 4.6 | GO:0006642 | triglyceride mobilization(GO:0006642) |
1.2 | 1.2 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
1.2 | 2.3 | GO:0035963 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
1.1 | 4.6 | GO:0002890 | negative regulation of B cell mediated immunity(GO:0002713) negative regulation of immunoglobulin mediated immune response(GO:0002890) |
1.1 | 3.4 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
1.1 | 8.0 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
1.1 | 6.8 | GO:0097264 | self proteolysis(GO:0097264) |
1.1 | 4.6 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
1.1 | 2.3 | GO:0002254 | kinin cascade(GO:0002254) |
1.1 | 3.4 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
1.1 | 9.1 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
1.1 | 4.5 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
1.1 | 2.3 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
1.1 | 6.8 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
1.1 | 7.9 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
1.1 | 14.7 | GO:0048853 | forebrain morphogenesis(GO:0048853) |
1.1 | 3.4 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
1.1 | 19.1 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
1.1 | 13.5 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
1.1 | 2.2 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
1.1 | 3.4 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
1.1 | 2.2 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
1.1 | 2.2 | GO:0021884 | forebrain neuron development(GO:0021884) |
1.1 | 3.3 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
1.1 | 3.3 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
1.1 | 1.1 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
1.1 | 6.7 | GO:0070327 | thyroid hormone transport(GO:0070327) |
1.1 | 3.3 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
1.1 | 12.2 | GO:0048854 | brain morphogenesis(GO:0048854) |
1.1 | 2.2 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
1.1 | 3.3 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
1.1 | 3.3 | GO:0006787 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) |
1.1 | 6.6 | GO:0016078 | tRNA catabolic process(GO:0016078) |
1.1 | 3.3 | GO:1903301 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
1.1 | 3.3 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
1.1 | 3.3 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
1.1 | 2.2 | GO:2000662 | interleukin-5 secretion(GO:0072603) interleukin-13 secretion(GO:0072611) regulation of interleukin-5 secretion(GO:2000662) positive regulation of interleukin-5 secretion(GO:2000664) regulation of interleukin-13 secretion(GO:2000665) positive regulation of interleukin-13 secretion(GO:2000667) |
1.1 | 3.3 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
1.1 | 1.1 | GO:0014732 | skeletal muscle atrophy(GO:0014732) |
1.1 | 36.0 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
1.1 | 7.6 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
1.1 | 5.4 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
1.1 | 4.3 | GO:0008655 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
1.1 | 2.2 | GO:1900157 | regulation of bone mineralization involved in bone maturation(GO:1900157) |
1.1 | 5.4 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
1.1 | 6.5 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
1.1 | 1.1 | GO:0060128 | corticotropin hormone secreting cell differentiation(GO:0060128) |
1.1 | 4.3 | GO:0042078 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
1.1 | 16.1 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
1.1 | 1.1 | GO:0052428 | negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
1.1 | 2.1 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
1.1 | 5.3 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
1.1 | 2.1 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
1.1 | 2.1 | GO:1902369 | negative regulation of RNA catabolic process(GO:1902369) |
1.1 | 4.3 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
1.1 | 8.5 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
1.1 | 2.1 | GO:0034727 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) late nucleophagy(GO:0044805) |
1.1 | 2.1 | GO:0001975 | response to amphetamine(GO:0001975) |
1.1 | 3.2 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
1.1 | 2.1 | GO:0071672 | negative regulation of smooth muscle cell chemotaxis(GO:0071672) |
1.1 | 3.2 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
1.1 | 3.2 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
1.1 | 4.2 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
1.1 | 16.8 | GO:0035640 | exploration behavior(GO:0035640) |
1.0 | 1.0 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
1.0 | 5.2 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
1.0 | 2.1 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
1.0 | 3.1 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
1.0 | 4.2 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
1.0 | 10.4 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
1.0 | 8.3 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
1.0 | 2.1 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
1.0 | 1.0 | GO:0006517 | protein deglycosylation(GO:0006517) |
1.0 | 7.2 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
1.0 | 6.2 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
1.0 | 3.1 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
1.0 | 1.0 | GO:0060437 | lung growth(GO:0060437) |
1.0 | 3.1 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
1.0 | 2.0 | GO:0009158 | ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
1.0 | 13.2 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
1.0 | 3.0 | GO:0010040 | response to iron(II) ion(GO:0010040) |
1.0 | 2.0 | GO:0046952 | ketone body catabolic process(GO:0046952) |
1.0 | 6.1 | GO:0051415 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
1.0 | 14.1 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
1.0 | 3.0 | GO:0008355 | olfactory learning(GO:0008355) |
1.0 | 5.0 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
1.0 | 2.0 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
1.0 | 7.0 | GO:0010388 | protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
1.0 | 3.0 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
1.0 | 4.0 | GO:0007258 | JUN phosphorylation(GO:0007258) |
1.0 | 6.0 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
1.0 | 1.0 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
1.0 | 1.0 | GO:0032025 | response to cobalt ion(GO:0032025) |
1.0 | 5.0 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
1.0 | 4.0 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
1.0 | 12.9 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
1.0 | 8.9 | GO:0036065 | fucosylation(GO:0036065) |
1.0 | 5.0 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
1.0 | 4.9 | GO:0042761 | very long-chain fatty acid biosynthetic process(GO:0042761) |
1.0 | 4.9 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
1.0 | 3.0 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
1.0 | 1.0 | GO:0006598 | polyamine catabolic process(GO:0006598) |
1.0 | 2.9 | GO:0006013 | mannose metabolic process(GO:0006013) |
1.0 | 2.0 | GO:0009106 | lipoate metabolic process(GO:0009106) |
1.0 | 2.9 | GO:0060618 | nipple development(GO:0060618) |
1.0 | 5.9 | GO:0015677 | copper ion import(GO:0015677) |
1.0 | 6.9 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
1.0 | 2.0 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
1.0 | 2.0 | GO:0051036 | regulation of endosome size(GO:0051036) |
1.0 | 4.9 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
1.0 | 3.9 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
1.0 | 2.9 | GO:0060729 | intestinal epithelial structure maintenance(GO:0060729) |
1.0 | 1.9 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
1.0 | 1.0 | GO:1900101 | regulation of endoplasmic reticulum unfolded protein response(GO:1900101) |
1.0 | 1.0 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
1.0 | 2.9 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
1.0 | 3.8 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
1.0 | 2.9 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
1.0 | 1.9 | GO:0046084 | adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
1.0 | 4.8 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
1.0 | 1.0 | GO:0006658 | phosphatidylserine metabolic process(GO:0006658) |
1.0 | 1.9 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
1.0 | 1.9 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
1.0 | 26.8 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
1.0 | 2.9 | GO:0007638 | mechanosensory behavior(GO:0007638) |
1.0 | 3.8 | GO:0030953 | astral microtubule organization(GO:0030953) |
1.0 | 1.0 | GO:0034372 | very-low-density lipoprotein particle remodeling(GO:0034372) |
0.9 | 11.4 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.9 | 2.8 | GO:0070666 | mast cell proliferation(GO:0070662) regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
0.9 | 1.9 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.9 | 4.7 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.9 | 0.9 | GO:0051231 | spindle elongation(GO:0051231) |
0.9 | 2.8 | GO:1904252 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.9 | 1.9 | GO:0071600 | otic vesicle morphogenesis(GO:0071600) |
0.9 | 6.5 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.9 | 0.9 | GO:2000152 | regulation of ubiquitin-specific protease activity(GO:2000152) |
0.9 | 1.8 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
0.9 | 1.8 | GO:0042231 | interleukin-13 biosynthetic process(GO:0042231) |
0.9 | 4.6 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.9 | 9.2 | GO:0001675 | acrosome assembly(GO:0001675) |
0.9 | 3.7 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
0.9 | 8.2 | GO:0021511 | spinal cord patterning(GO:0021511) |
0.9 | 0.9 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
0.9 | 4.6 | GO:0060746 | parental behavior(GO:0060746) |
0.9 | 2.7 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
0.9 | 12.7 | GO:1904872 | regulation of telomerase RNA localization to Cajal body(GO:1904872) positive regulation of telomerase RNA localization to Cajal body(GO:1904874) |
0.9 | 4.5 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.9 | 2.7 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.9 | 4.5 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.9 | 2.7 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.9 | 0.9 | GO:0060166 | olfactory pit development(GO:0060166) |
0.9 | 3.6 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.9 | 1.8 | GO:0044783 | mitotic G1 DNA damage checkpoint(GO:0031571) G1 DNA damage checkpoint(GO:0044783) |
0.9 | 6.2 | GO:0002485 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
0.9 | 4.4 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.9 | 1.8 | GO:0042322 | negative regulation of circadian sleep/wake cycle, REM sleep(GO:0042322) |
0.9 | 1.8 | GO:0035523 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.9 | 1.8 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.9 | 0.9 | GO:0051584 | regulation of dopamine uptake involved in synaptic transmission(GO:0051584) regulation of catecholamine uptake involved in synaptic transmission(GO:0051940) |
0.9 | 1.8 | GO:0061084 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
0.9 | 2.7 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.9 | 2.6 | GO:0071638 | negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
0.9 | 6.2 | GO:0043496 | regulation of protein homodimerization activity(GO:0043496) |
0.9 | 3.5 | GO:0015822 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
0.9 | 0.9 | GO:0090135 | actin filament branching(GO:0090135) |
0.9 | 5.3 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.9 | 6.2 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
0.9 | 6.1 | GO:0050655 | dermatan sulfate proteoglycan metabolic process(GO:0050655) |
0.9 | 1.7 | GO:0051031 | tRNA transport(GO:0051031) |
0.9 | 9.6 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.9 | 0.9 | GO:0036498 | IRE1-mediated unfolded protein response(GO:0036498) |
0.9 | 3.5 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
0.9 | 2.6 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
0.9 | 4.3 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.9 | 1.7 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.9 | 2.6 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.9 | 4.3 | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.9 | 6.9 | GO:0070129 | regulation of mitochondrial translation(GO:0070129) |
0.9 | 7.7 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.9 | 0.9 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
0.9 | 3.4 | GO:0021854 | hypothalamus development(GO:0021854) |
0.9 | 1.7 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
0.9 | 2.6 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.8 | 1.7 | GO:0046040 | IMP metabolic process(GO:0046040) |
0.8 | 3.4 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.8 | 5.1 | GO:0006828 | manganese ion transport(GO:0006828) |
0.8 | 4.2 | GO:0006983 | ER overload response(GO:0006983) |
0.8 | 1.7 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
0.8 | 5.1 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.8 | 6.8 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.8 | 5.1 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.8 | 2.5 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.8 | 0.8 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.8 | 1.7 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
0.8 | 4.2 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.8 | 1.7 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.8 | 1.7 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.8 | 4.2 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.8 | 7.6 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.8 | 2.5 | GO:0001302 | replicative cell aging(GO:0001302) |
0.8 | 5.9 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.8 | 2.5 | GO:0046130 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
0.8 | 2.5 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.8 | 52.0 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.8 | 3.3 | GO:1990592 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.8 | 0.8 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.8 | 0.8 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
0.8 | 4.2 | GO:0070459 | prolactin secretion(GO:0070459) |
0.8 | 0.8 | GO:0090493 | catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
0.8 | 1.7 | GO:0032849 | positive regulation of cellular pH reduction(GO:0032849) |
0.8 | 11.7 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.8 | 17.5 | GO:1901998 | toxin transport(GO:1901998) |
0.8 | 3.3 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.8 | 0.8 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.8 | 0.8 | GO:1904193 | cholangiocyte apoptotic process(GO:1902488) regulation of cholangiocyte apoptotic process(GO:1904192) negative regulation of cholangiocyte apoptotic process(GO:1904193) |
0.8 | 5.0 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.8 | 10.0 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.8 | 2.5 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.8 | 2.5 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.8 | 2.5 | GO:0032430 | positive regulation of phospholipase A2 activity(GO:0032430) |
0.8 | 1.7 | GO:2000598 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.8 | 14.0 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.8 | 9.9 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.8 | 10.7 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.8 | 3.3 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.8 | 9.0 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.8 | 27.0 | GO:0007041 | lysosomal transport(GO:0007041) |
0.8 | 2.5 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
0.8 | 4.1 | GO:1901673 | regulation of mitotic spindle assembly(GO:1901673) |
0.8 | 2.5 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.8 | 1.6 | GO:0018342 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
0.8 | 2.4 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.8 | 4.9 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.8 | 4.9 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.8 | 2.4 | GO:0009838 | abscission(GO:0009838) |
0.8 | 10.5 | GO:0035418 | protein localization to synapse(GO:0035418) |
0.8 | 16.2 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.8 | 4.8 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.8 | 2.4 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.8 | 1.6 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.8 | 2.4 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.8 | 4.0 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.8 | 4.0 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.8 | 0.8 | GO:0042538 | hyperosmotic salinity response(GO:0042538) |
0.8 | 2.4 | GO:0031116 | positive regulation of microtubule polymerization(GO:0031116) |
0.8 | 4.0 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.8 | 1.6 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.8 | 0.8 | GO:0071166 | ribonucleoprotein complex localization(GO:0071166) |
0.8 | 1.6 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.8 | 7.1 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.8 | 4.7 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.8 | 1.6 | GO:0007063 | regulation of sister chromatid cohesion(GO:0007063) |
0.8 | 7.1 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.8 | 1.6 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
0.8 | 0.8 | GO:0045048 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.8 | 4.7 | GO:0060736 | prostate gland growth(GO:0060736) |
0.8 | 8.6 | GO:0051647 | nucleus localization(GO:0051647) |
0.8 | 3.9 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.8 | 3.1 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.8 | 1.6 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.8 | 5.5 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) |
0.8 | 3.1 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.8 | 2.3 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.8 | 1.6 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.8 | 4.7 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.8 | 0.8 | GO:0014824 | artery smooth muscle contraction(GO:0014824) |
0.8 | 2.3 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.8 | 1.5 | GO:0010042 | response to manganese ion(GO:0010042) |
0.8 | 1.5 | GO:0021871 | forebrain regionalization(GO:0021871) |
0.8 | 7.7 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.8 | 2.3 | GO:0021554 | optic nerve development(GO:0021554) |
0.8 | 10.0 | GO:0007031 | peroxisome organization(GO:0007031) |
0.8 | 6.1 | GO:0046500 | S-adenosylmethionine metabolic process(GO:0046500) |
0.8 | 6.9 | GO:0001964 | startle response(GO:0001964) |
0.8 | 1.5 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.8 | 5.4 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.8 | 8.4 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.8 | 0.8 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
0.8 | 6.1 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.8 | 0.8 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
0.8 | 3.0 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.8 | 10.7 | GO:0030488 | tRNA methylation(GO:0030488) |
0.8 | 1.5 | GO:0051788 | response to misfolded protein(GO:0051788) |
0.8 | 3.8 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.8 | 9.8 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.7 | 2.2 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.7 | 0.7 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
0.7 | 3.7 | GO:0060179 | male mating behavior(GO:0060179) |
0.7 | 2.2 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.7 | 6.7 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.7 | 2.2 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.7 | 2.2 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.7 | 1.5 | GO:1902896 | terminal web assembly(GO:1902896) |
0.7 | 6.7 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
0.7 | 6.7 | GO:0032392 | DNA geometric change(GO:0032392) |
0.7 | 2.9 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.7 | 0.7 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.7 | 2.2 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.7 | 2.2 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.7 | 2.9 | GO:0014719 | skeletal muscle satellite cell activation(GO:0014719) |
0.7 | 7.3 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.7 | 4.4 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.7 | 1.4 | GO:1900084 | regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
0.7 | 4.3 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.7 | 2.9 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
0.7 | 3.6 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.7 | 3.6 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.7 | 1.4 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.7 | 0.7 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.7 | 1.4 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.7 | 0.7 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.7 | 2.9 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
0.7 | 22.8 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.7 | 0.7 | GO:0032056 | positive regulation of translation in response to stress(GO:0032056) |
0.7 | 6.4 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.7 | 1.4 | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) |
0.7 | 4.3 | GO:0006266 | DNA ligation(GO:0006266) |
0.7 | 4.2 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.7 | 1.4 | GO:0043649 | dicarboxylic acid catabolic process(GO:0043649) |
0.7 | 0.7 | GO:0002536 | respiratory burst involved in inflammatory response(GO:0002536) |
0.7 | 4.9 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
0.7 | 2.8 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.7 | 2.1 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.7 | 2.8 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.7 | 7.0 | GO:0035879 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.7 | 2.1 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.7 | 1.4 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
0.7 | 3.5 | GO:0043970 | histone H3-K9 acetylation(GO:0043970) regulation of histone H3-K9 acetylation(GO:2000615) |
0.7 | 0.7 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.7 | 4.2 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.7 | 9.1 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.7 | 7.0 | GO:0003334 | keratinocyte development(GO:0003334) |
0.7 | 14.0 | GO:0050775 | positive regulation of dendrite morphogenesis(GO:0050775) |
0.7 | 10.5 | GO:0036465 | synaptic vesicle recycling(GO:0036465) |
0.7 | 2.1 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
0.7 | 2.1 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
0.7 | 2.8 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.7 | 3.5 | GO:0007207 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.7 | 2.8 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.7 | 22.7 | GO:0043039 | tRNA aminoacylation(GO:0043039) |
0.7 | 4.8 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.7 | 2.1 | GO:1903232 | melanosome assembly(GO:1903232) |
0.7 | 1.4 | GO:0002905 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.7 | 2.7 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.7 | 1.4 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.7 | 2.7 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.7 | 1.4 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.7 | 3.4 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.7 | 3.4 | GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
0.7 | 7.5 | GO:0043248 | proteasome assembly(GO:0043248) |
0.7 | 2.0 | GO:0043691 | reverse cholesterol transport(GO:0043691) |
0.7 | 2.0 | GO:0021778 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
0.7 | 4.7 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.7 | 6.1 | GO:0001963 | synaptic transmission, dopaminergic(GO:0001963) |
0.7 | 7.4 | GO:0006400 | tRNA modification(GO:0006400) |
0.7 | 2.7 | GO:1904415 | regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
0.7 | 0.7 | GO:0097090 | presynaptic membrane organization(GO:0097090) |
0.7 | 3.3 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.7 | 4.0 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.7 | 0.7 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.7 | 2.0 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.7 | 4.0 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.7 | 10.0 | GO:0035176 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.7 | 2.0 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.7 | 7.3 | GO:0033108 | mitochondrial respiratory chain complex assembly(GO:0033108) |
0.7 | 0.7 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.7 | 0.7 | GO:2000780 | negative regulation of double-strand break repair(GO:2000780) |
0.7 | 4.0 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.7 | 4.0 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.7 | 19.8 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.7 | 1.3 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.7 | 3.3 | GO:0071910 | determination of liver left/right asymmetry(GO:0071910) |
0.7 | 2.6 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.7 | 2.0 | GO:0046078 | dUMP metabolic process(GO:0046078) |
0.7 | 1.3 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.7 | 1.3 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.7 | 2.6 | GO:0060768 | epithelial cell proliferation involved in prostate gland development(GO:0060767) regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) |
0.7 | 1.3 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.6 | 2.6 | GO:0002070 | epithelial cell maturation(GO:0002070) |
0.6 | 4.5 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.6 | 0.6 | GO:0010996 | response to auditory stimulus(GO:0010996) |
0.6 | 3.2 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.6 | 1.3 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
0.6 | 10.8 | GO:0001881 | receptor recycling(GO:0001881) |
0.6 | 3.8 | GO:0006825 | copper ion transport(GO:0006825) |
0.6 | 1.9 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.6 | 0.6 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.6 | 0.6 | GO:0072393 | microtubule anchoring at microtubule organizing center(GO:0072393) |
0.6 | 3.8 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.6 | 1.3 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.6 | 0.6 | GO:0010873 | positive regulation of cholesterol esterification(GO:0010873) |
0.6 | 1.3 | GO:0030202 | heparin metabolic process(GO:0030202) |
0.6 | 1.9 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
0.6 | 1.9 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.6 | 1.2 | GO:0030576 | Cajal body organization(GO:0030576) |
0.6 | 1.9 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.6 | 4.4 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
0.6 | 0.6 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
0.6 | 1.2 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
0.6 | 1.2 | GO:2000020 | positive regulation of male gonad development(GO:2000020) |
0.6 | 2.5 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
0.6 | 1.9 | GO:0006684 | sphingomyelin metabolic process(GO:0006684) |
0.6 | 3.1 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.6 | 21.7 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.6 | 1.2 | GO:0006562 | proline catabolic process(GO:0006562) |
0.6 | 6.2 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.6 | 3.1 | GO:0044068 | modulation by symbiont of host cellular process(GO:0044068) |
0.6 | 1.8 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.6 | 3.7 | GO:0031167 | rRNA methylation(GO:0031167) |
0.6 | 3.6 | GO:0010661 | positive regulation of muscle cell apoptotic process(GO:0010661) |
0.6 | 7.9 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.6 | 17.6 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.6 | 4.8 | GO:0072395 | signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in DNA damage checkpoint(GO:0072422) |
0.6 | 0.6 | GO:0090069 | regulation of ribosome biogenesis(GO:0090069) |
0.6 | 7.9 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.6 | 3.6 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.6 | 1.8 | GO:0034770 | histone H4-K20 methylation(GO:0034770) histone H4-K20 trimethylation(GO:0034773) |
0.6 | 1.2 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.6 | 12.7 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.6 | 1.2 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.6 | 1.2 | GO:0051410 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.6 | 0.6 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.6 | 8.4 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.6 | 8.4 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.6 | 3.0 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.6 | 0.6 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
0.6 | 4.7 | GO:0031643 | positive regulation of myelination(GO:0031643) |
0.6 | 1.8 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
0.6 | 1.2 | GO:0010613 | positive regulation of cardiac muscle hypertrophy(GO:0010613) positive regulation of muscle hypertrophy(GO:0014742) |
0.6 | 0.6 | GO:0060547 | negative regulation of necrotic cell death(GO:0060547) |
0.6 | 2.3 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.6 | 8.2 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
0.6 | 0.6 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.6 | 17.5 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.6 | 1.7 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.6 | 1.7 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.6 | 2.3 | GO:0033227 | dsRNA transport(GO:0033227) |
0.6 | 6.4 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.6 | 10.9 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.6 | 8.1 | GO:0016180 | snRNA processing(GO:0016180) |
0.6 | 1.1 | GO:0071371 | cellular response to gonadotropin stimulus(GO:0071371) |
0.6 | 1.1 | GO:0006984 | ER-nucleus signaling pathway(GO:0006984) |
0.6 | 4.0 | GO:0046470 | phosphatidylcholine metabolic process(GO:0046470) |
0.6 | 4.0 | GO:0051646 | mitochondrion localization(GO:0051646) |
0.6 | 7.9 | GO:1902850 | mitotic spindle assembly(GO:0090307) microtubule cytoskeleton organization involved in mitosis(GO:1902850) |
0.6 | 2.8 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.6 | 3.4 | GO:0051642 | centrosome localization(GO:0051642) |
0.6 | 1.7 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.6 | 12.4 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.6 | 13.5 | GO:0006778 | porphyrin-containing compound metabolic process(GO:0006778) |
0.6 | 1.7 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.6 | 2.2 | GO:1903998 | regulation of eating behavior(GO:1903998) |
0.6 | 3.3 | GO:0042987 | amyloid precursor protein catabolic process(GO:0042987) |
0.6 | 10.0 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
0.6 | 2.8 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.6 | 1.1 | GO:0019346 | homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) hydrogen sulfide biosynthetic process(GO:0070814) |
0.6 | 4.4 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
0.6 | 2.8 | GO:1903441 | protein localization to ciliary membrane(GO:1903441) |
0.6 | 1.7 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.6 | 2.8 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.6 | 2.2 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
0.6 | 0.6 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
0.5 | 2.7 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.5 | 1.6 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
0.5 | 7.1 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.5 | 2.2 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.5 | 3.3 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.5 | 4.4 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.5 | 1.1 | GO:0051966 | regulation of synaptic transmission, glutamatergic(GO:0051966) |
0.5 | 1.1 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.5 | 1.1 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.5 | 0.5 | GO:0060631 | regulation of meiosis I(GO:0060631) |
0.5 | 2.1 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.5 | 0.5 | GO:0040031 | snRNA modification(GO:0040031) |
0.5 | 5.9 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.5 | 1.6 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.5 | 1.6 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.5 | 4.2 | GO:0042417 | dopamine metabolic process(GO:0042417) |
0.5 | 1.6 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.5 | 0.5 | GO:1903011 | negative regulation of bone development(GO:1903011) |
0.5 | 2.1 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.5 | 1.0 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.5 | 1.6 | GO:0034433 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.5 | 0.5 | GO:0008334 | histone mRNA metabolic process(GO:0008334) |
0.5 | 3.1 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.5 | 5.7 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.5 | 1.5 | GO:0036135 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
0.5 | 6.7 | GO:0008210 | estrogen metabolic process(GO:0008210) |
0.5 | 2.1 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.5 | 1.0 | GO:0014832 | urinary bladder smooth muscle contraction(GO:0014832) |
0.5 | 0.5 | GO:1903977 | positive regulation of glial cell migration(GO:1903977) |
0.5 | 4.6 | GO:0033750 | ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) |
0.5 | 0.5 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) negative regulation of respiratory burst(GO:0060268) |
0.5 | 1.0 | GO:0021794 | thalamus development(GO:0021794) |
0.5 | 8.6 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.5 | 3.5 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.5 | 3.0 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.5 | 5.5 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.5 | 5.0 | GO:0009209 | pyrimidine ribonucleoside triphosphate biosynthetic process(GO:0009209) |
0.5 | 0.5 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.5 | 2.0 | GO:1900363 | regulation of mRNA polyadenylation(GO:1900363) |
0.5 | 16.9 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.5 | 5.5 | GO:0009081 | branched-chain amino acid metabolic process(GO:0009081) branched-chain amino acid catabolic process(GO:0009083) |
0.5 | 1.5 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.5 | 0.5 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.5 | 1.5 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
0.5 | 17.1 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.5 | 1.5 | GO:0035358 | regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035358) |
0.5 | 2.0 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.5 | 1.0 | GO:0008206 | bile acid metabolic process(GO:0008206) |
0.5 | 1.5 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
0.5 | 1.9 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.5 | 1.4 | GO:0097501 | stress response to metal ion(GO:0097501) |
0.5 | 5.3 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.5 | 1.4 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.5 | 3.8 | GO:0045471 | response to ethanol(GO:0045471) |
0.5 | 10.1 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.5 | 1.9 | GO:0060613 | fat pad development(GO:0060613) |
0.5 | 0.5 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.5 | 1.0 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.5 | 0.5 | GO:0007567 | parturition(GO:0007567) |
0.5 | 1.0 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.5 | 2.4 | GO:0031646 | positive regulation of neurological system process(GO:0031646) |
0.5 | 0.5 | GO:0090045 | positive regulation of deacetylase activity(GO:0090045) |
0.5 | 0.5 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.5 | 4.7 | GO:0006101 | citrate metabolic process(GO:0006101) |
0.5 | 0.5 | GO:0045585 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.5 | 0.5 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.5 | 1.9 | GO:1903961 | positive regulation of anion transmembrane transport(GO:1903961) |
0.5 | 0.5 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.5 | 1.4 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.5 | 0.9 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.5 | 9.2 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.5 | 1.4 | GO:0048755 | branching morphogenesis of a nerve(GO:0048755) |
0.5 | 0.9 | GO:0003105 | negative regulation of glomerular filtration(GO:0003105) |
0.5 | 3.7 | GO:0051602 | response to electrical stimulus(GO:0051602) |
0.5 | 17.3 | GO:0008033 | tRNA processing(GO:0008033) |
0.5 | 0.5 | GO:0097066 | response to thyroid hormone(GO:0097066) |
0.5 | 5.0 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
0.5 | 0.9 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.5 | 1.4 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
0.5 | 2.7 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.5 | 0.5 | GO:0009162 | deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
0.5 | 0.5 | GO:0051204 | protein insertion into mitochondrial membrane(GO:0051204) |
0.4 | 4.0 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.4 | 0.4 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
0.4 | 1.8 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.4 | 0.4 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
0.4 | 1.3 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
0.4 | 6.7 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.4 | 0.9 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.4 | 1.3 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
0.4 | 15.5 | GO:0051297 | centrosome organization(GO:0051297) |
0.4 | 2.6 | GO:0022406 | membrane docking(GO:0022406) |
0.4 | 0.9 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.4 | 0.9 | GO:0050957 | equilibrioception(GO:0050957) |
0.4 | 1.3 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.4 | 2.6 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.4 | 7.9 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.4 | 3.1 | GO:0030825 | positive regulation of cGMP metabolic process(GO:0030825) positive regulation of cGMP biosynthetic process(GO:0030828) |
0.4 | 2.6 | GO:0002566 | somatic diversification of immune receptors via somatic mutation(GO:0002566) |
0.4 | 3.5 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.4 | 1.3 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.4 | 21.6 | GO:0006818 | hydrogen transport(GO:0006818) |
0.4 | 1.3 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.4 | 11.2 | GO:0043507 | positive regulation of JUN kinase activity(GO:0043507) |
0.4 | 4.7 | GO:0006119 | oxidative phosphorylation(GO:0006119) |
0.4 | 2.6 | GO:0015074 | DNA integration(GO:0015074) |
0.4 | 4.3 | GO:0071539 | protein localization to centrosome(GO:0071539) |
0.4 | 2.5 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.4 | 1.7 | GO:0031664 | regulation of lipopolysaccharide-mediated signaling pathway(GO:0031664) |
0.4 | 4.2 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
0.4 | 1.3 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.4 | 6.7 | GO:0071472 | cellular response to salt stress(GO:0071472) |
0.4 | 0.4 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.4 | 10.9 | GO:0001895 | retina homeostasis(GO:0001895) |
0.4 | 3.3 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.4 | 2.1 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
0.4 | 1.2 | GO:0022904 | respiratory electron transport chain(GO:0022904) |
0.4 | 2.1 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
0.4 | 2.1 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.4 | 1.2 | GO:0072528 | pyrimidine-containing compound biosynthetic process(GO:0072528) |
0.4 | 0.4 | GO:0034204 | lipid translocation(GO:0034204) |
0.4 | 0.4 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.4 | 0.8 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.4 | 14.8 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.4 | 4.9 | GO:0099517 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.4 | 0.8 | GO:1901874 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.4 | 0.4 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.4 | 1.2 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.4 | 1.2 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.4 | 0.4 | GO:0045472 | response to ether(GO:0045472) |
0.4 | 2.0 | GO:0097237 | cellular response to toxic substance(GO:0097237) |
0.4 | 2.8 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.4 | 0.4 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.4 | 0.8 | GO:0035337 | fatty-acyl-CoA metabolic process(GO:0035337) |
0.4 | 1.6 | GO:0060632 | regulation of microtubule-based movement(GO:0060632) |
0.4 | 1.2 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
0.4 | 5.6 | GO:0008542 | visual learning(GO:0008542) |
0.4 | 0.4 | GO:0046134 | pyrimidine nucleoside biosynthetic process(GO:0046134) |
0.4 | 0.8 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.4 | 0.8 | GO:0006972 | hyperosmotic response(GO:0006972) |
0.4 | 4.3 | GO:0030033 | microvillus assembly(GO:0030033) |
0.4 | 1.6 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.4 | 1.6 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.4 | 2.4 | GO:0006465 | signal peptide processing(GO:0006465) |
0.4 | 0.8 | GO:0003139 | secondary heart field specification(GO:0003139) |
0.4 | 1.2 | GO:0001806 | type IV hypersensitivity(GO:0001806) |
0.4 | 3.1 | GO:0050805 | negative regulation of synaptic transmission(GO:0050805) |
0.4 | 0.8 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.4 | 8.2 | GO:0006892 | post-Golgi vesicle-mediated transport(GO:0006892) |
0.4 | 1.2 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.4 | 0.8 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.4 | 1.6 | GO:0009438 | methylglyoxal metabolic process(GO:0009438) |
0.4 | 2.3 | GO:0043094 | cellular metabolic compound salvage(GO:0043094) |
0.4 | 0.4 | GO:0072423 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
0.4 | 0.8 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.4 | 1.9 | GO:2000505 | regulation of energy homeostasis(GO:2000505) |
0.4 | 1.5 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.4 | 1.1 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.4 | 0.8 | GO:0045226 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.4 | 3.8 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.4 | 4.6 | GO:0006706 | steroid catabolic process(GO:0006706) |
0.4 | 0.8 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.4 | 1.5 | GO:0071971 | extracellular exosome assembly(GO:0071971) regulation of extracellular exosome assembly(GO:1903551) |
0.4 | 1.1 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
0.4 | 1.1 | GO:0035627 | ceramide transport(GO:0035627) |
0.4 | 0.7 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
0.4 | 1.5 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.4 | 1.1 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.4 | 4.7 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
0.4 | 1.8 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.4 | 1.5 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.4 | 29.4 | GO:0016072 | rRNA metabolic process(GO:0016072) |
0.4 | 7.9 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.4 | 2.5 | GO:0098734 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.4 | 0.7 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.4 | 1.4 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.4 | 2.5 | GO:2000772 | regulation of cellular senescence(GO:2000772) |
0.4 | 0.7 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
0.4 | 1.8 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.4 | 0.4 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.4 | 0.4 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
0.4 | 1.1 | GO:1990403 | embryonic brain development(GO:1990403) |
0.3 | 2.4 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.3 | 1.4 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.3 | 1.4 | GO:0015867 | ATP transport(GO:0015867) |
0.3 | 1.0 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.3 | 1.0 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.3 | 0.7 | GO:0050955 | thermoception(GO:0050955) |
0.3 | 0.7 | GO:0000087 | mitotic M phase(GO:0000087) |
0.3 | 2.4 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.3 | 12.5 | GO:0098656 | anion transmembrane transport(GO:0098656) |
0.3 | 0.3 | GO:1901016 | regulation of potassium ion transmembrane transporter activity(GO:1901016) |
0.3 | 0.3 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.3 | 0.7 | GO:0015755 | fructose transport(GO:0015755) |
0.3 | 2.3 | GO:0098543 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.3 | 3.0 | GO:0045056 | transcytosis(GO:0045056) |
0.3 | 6.3 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.3 | 2.6 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.3 | 0.3 | GO:0045002 | double-strand break repair via single-strand annealing(GO:0045002) |
0.3 | 1.0 | GO:0033136 | serine phosphorylation of STAT3 protein(GO:0033136) |
0.3 | 3.2 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.3 | 2.9 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.3 | 0.6 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.3 | 2.2 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.3 | 1.0 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.3 | 1.0 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.3 | 1.6 | GO:1905145 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.3 | 0.3 | GO:0002339 | B cell selection(GO:0002339) |
0.3 | 2.8 | GO:0046677 | response to antibiotic(GO:0046677) |
0.3 | 0.6 | GO:0010744 | positive regulation of macrophage derived foam cell differentiation(GO:0010744) |
0.3 | 0.6 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.3 | 0.3 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.3 | 6.8 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.3 | 1.5 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
0.3 | 0.9 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.3 | 1.2 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.3 | 1.5 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.3 | 1.2 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.3 | 0.6 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.3 | 1.2 | GO:0065002 | intracellular protein transmembrane transport(GO:0065002) protein transmembrane transport(GO:0071806) |
0.3 | 0.6 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.3 | 0.9 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.3 | 0.6 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.3 | 4.5 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.3 | 1.2 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.3 | 0.9 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.3 | 0.9 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
0.3 | 10.5 | GO:0009062 | fatty acid catabolic process(GO:0009062) |
0.3 | 0.3 | GO:0061209 | cell proliferation involved in mesonephros development(GO:0061209) |
0.3 | 0.9 | GO:0006591 | ornithine metabolic process(GO:0006591) |
0.3 | 0.9 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.3 | 2.3 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.3 | 1.4 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.3 | 1.7 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
0.3 | 0.6 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.3 | 2.3 | GO:0043631 | mRNA polyadenylation(GO:0006378) RNA polyadenylation(GO:0043631) |
0.3 | 2.3 | GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
0.3 | 0.8 | GO:0022900 | electron transport chain(GO:0022900) |
0.3 | 1.4 | GO:0045779 | negative regulation of bone resorption(GO:0045779) |
0.3 | 0.8 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
0.3 | 2.2 | GO:0006743 | ubiquinone metabolic process(GO:0006743) |
0.3 | 3.6 | GO:0001782 | B cell homeostasis(GO:0001782) |
0.3 | 0.3 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.3 | 2.2 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.3 | 0.3 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.3 | 0.3 | GO:0008215 | spermine metabolic process(GO:0008215) |
0.3 | 0.6 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.3 | 13.2 | GO:0006836 | neurotransmitter transport(GO:0006836) |
0.3 | 5.2 | GO:1902807 | negative regulation of cell cycle G1/S phase transition(GO:1902807) |
0.3 | 3.6 | GO:0097178 | ruffle assembly(GO:0097178) |
0.3 | 23.3 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
0.3 | 0.5 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.3 | 3.0 | GO:0007612 | learning(GO:0007612) |
0.3 | 1.1 | GO:0043987 | histone-serine phosphorylation(GO:0035404) histone H3-S10 phosphorylation(GO:0043987) |
0.3 | 0.3 | GO:0090383 | phagosome acidification(GO:0090383) |
0.3 | 2.2 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
0.3 | 0.8 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.3 | 0.3 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) positive regulation of hh target transcription factor activity(GO:0007228) |
0.3 | 1.6 | GO:0060539 | diaphragm development(GO:0060539) |
0.3 | 0.8 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.3 | 1.6 | GO:0007004 | RNA-dependent DNA biosynthetic process(GO:0006278) telomere maintenance via telomerase(GO:0007004) |
0.3 | 4.0 | GO:0007340 | acrosome reaction(GO:0007340) |
0.3 | 0.5 | GO:0035425 | autocrine signaling(GO:0035425) |
0.3 | 4.5 | GO:1901216 | positive regulation of neuron death(GO:1901216) |
0.3 | 1.1 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
0.3 | 0.5 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.3 | 0.5 | GO:0008306 | associative learning(GO:0008306) |
0.3 | 0.5 | GO:0071468 | cellular response to acidic pH(GO:0071468) |
0.3 | 0.3 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.3 | 0.5 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.3 | 1.5 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.3 | 1.0 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.3 | 0.3 | GO:0031627 | telomeric loop formation(GO:0031627) |
0.3 | 0.3 | GO:0044090 | positive regulation of vacuole organization(GO:0044090) regulation of macromitophagy(GO:1901524) |
0.3 | 0.8 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.2 | 0.2 | GO:0003331 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
0.2 | 1.0 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.2 | 1.7 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.2 | 0.2 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.2 | 4.4 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.2 | 3.9 | GO:0021987 | cerebral cortex development(GO:0021987) |
0.2 | 1.5 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.2 | 2.2 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.2 | 1.2 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.2 | 0.7 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.2 | 0.2 | GO:0060029 | convergent extension involved in organogenesis(GO:0060029) |
0.2 | 2.9 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.2 | 0.5 | GO:0035865 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.2 | 1.0 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.2 | 0.5 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.2 | 3.1 | GO:0048821 | erythrocyte development(GO:0048821) |
0.2 | 0.9 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.2 | 0.9 | GO:0048520 | positive regulation of behavior(GO:0048520) |
0.2 | 0.7 | GO:0002002 | regulation of angiotensin levels in blood(GO:0002002) |
0.2 | 2.7 | GO:0051180 | vitamin transport(GO:0051180) |
0.2 | 0.9 | GO:0009072 | aromatic amino acid family metabolic process(GO:0009072) |
0.2 | 0.2 | GO:0014745 | negative regulation of muscle adaptation(GO:0014745) |
0.2 | 0.7 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.2 | 0.4 | GO:0034982 | mitochondrial protein processing(GO:0034982) |
0.2 | 0.9 | GO:0016233 | telomere capping(GO:0016233) |
0.2 | 0.7 | GO:0060900 | embryonic camera-type eye formation(GO:0060900) |
0.2 | 3.1 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.2 | 1.3 | GO:0006677 | glycosylceramide metabolic process(GO:0006677) |
0.2 | 0.2 | GO:0002215 | defense response to nematode(GO:0002215) |
0.2 | 1.5 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.2 | 0.6 | GO:0010715 | regulation of extracellular matrix disassembly(GO:0010715) |
0.2 | 1.3 | GO:0098739 | sodium ion import(GO:0097369) import across plasma membrane(GO:0098739) |
0.2 | 10.4 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
0.2 | 0.4 | GO:0060079 | excitatory postsynaptic potential(GO:0060079) |
0.2 | 0.6 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.2 | 0.2 | GO:0015705 | iodide transport(GO:0015705) |
0.2 | 0.2 | GO:0043038 | amino acid activation(GO:0043038) |
0.2 | 10.0 | GO:0098792 | xenophagy(GO:0098792) |
0.2 | 0.4 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
0.2 | 1.4 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.2 | 0.2 | GO:0033505 | floor plate morphogenesis(GO:0033505) |
0.2 | 1.4 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.2 | 0.6 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
0.2 | 1.0 | GO:0009225 | nucleotide-sugar metabolic process(GO:0009225) |
0.2 | 7.1 | GO:0044839 | cell cycle G2/M phase transition(GO:0044839) |
0.2 | 0.2 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.2 | 0.2 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.2 | 0.4 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.2 | 0.6 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.2 | 3.7 | GO:0042255 | ribosome assembly(GO:0042255) |
0.2 | 1.9 | GO:0046348 | amino sugar catabolic process(GO:0046348) |
0.2 | 0.4 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.2 | 1.5 | GO:0015909 | long-chain fatty acid transport(GO:0015909) |
0.2 | 0.2 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.2 | 4.9 | GO:0051028 | mRNA transport(GO:0051028) |
0.2 | 1.5 | GO:0006921 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) apoptotic nuclear changes(GO:0030262) |
0.2 | 0.2 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.2 | 0.2 | GO:0032831 | positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
0.2 | 2.2 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.2 | 0.6 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
0.2 | 0.2 | GO:0046668 | regulation of retinal cell programmed cell death(GO:0046668) |
0.2 | 1.1 | GO:0045739 | positive regulation of DNA repair(GO:0045739) |
0.2 | 0.4 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.2 | 0.9 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.2 | 1.6 | GO:0006998 | nuclear envelope organization(GO:0006998) |
0.2 | 3.8 | GO:0019835 | cytolysis(GO:0019835) |
0.2 | 0.4 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.2 | 0.5 | GO:0030920 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.2 | 1.2 | GO:0060008 | Sertoli cell differentiation(GO:0060008) |
0.2 | 0.2 | GO:0006108 | malate metabolic process(GO:0006108) |
0.2 | 0.7 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.2 | 1.2 | GO:0030641 | regulation of cellular pH(GO:0030641) |
0.2 | 0.5 | GO:1904729 | regulation of intestinal lipid absorption(GO:1904729) |
0.2 | 0.3 | GO:0090009 | primitive streak formation(GO:0090009) |
0.2 | 0.2 | GO:0009208 | pyrimidine ribonucleoside triphosphate metabolic process(GO:0009208) |
0.2 | 0.7 | GO:1901725 | regulation of histone deacetylase activity(GO:1901725) |
0.2 | 6.3 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.2 | 0.3 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.2 | 0.7 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.2 | 0.3 | GO:0009065 | glutamine family amino acid catabolic process(GO:0009065) |
0.2 | 0.8 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.2 | 0.3 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.2 | 0.5 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.2 | 0.2 | GO:0002674 | negative regulation of acute inflammatory response(GO:0002674) |
0.2 | 0.2 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
0.2 | 1.0 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.2 | 0.2 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.2 | 0.3 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
0.2 | 0.5 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.2 | 0.9 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.1 | 0.7 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.1 | 0.1 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.1 | 0.1 | GO:0045423 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.1 | 0.4 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
0.1 | 1.0 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.1 | 0.7 | GO:0097194 | execution phase of apoptosis(GO:0097194) |
0.1 | 2.4 | GO:0002437 | inflammatory response to antigenic stimulus(GO:0002437) |
0.1 | 0.1 | GO:0071609 | chemokine (C-C motif) ligand 5 production(GO:0071609) |
0.1 | 0.3 | GO:0045910 | negative regulation of DNA recombination(GO:0045910) |
0.1 | 0.6 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.1 | 0.7 | GO:0018200 | peptidyl-glutamic acid modification(GO:0018200) |
0.1 | 0.8 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.1 | 1.0 | GO:0044146 | negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
0.1 | 0.5 | GO:0070234 | positive regulation of T cell apoptotic process(GO:0070234) |
0.1 | 0.3 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.1 | 1.2 | GO:0016926 | protein desumoylation(GO:0016926) |
0.1 | 0.3 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.1 | 0.4 | GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
0.1 | 0.1 | GO:0034969 | histone arginine methylation(GO:0034969) |
0.1 | 0.1 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.1 | 0.8 | GO:0006071 | glycerol metabolic process(GO:0006071) |
0.1 | 0.9 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.1 | 0.3 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.1 | 0.3 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
0.1 | 0.1 | GO:0060662 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.1 | 0.2 | GO:0045916 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.1 | 0.1 | GO:0002589 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) |
0.1 | 0.1 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.1 | 0.2 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
0.1 | 0.1 | GO:1904467 | regulation of tumor necrosis factor secretion(GO:1904467) tumor necrosis factor secretion(GO:1990774) |
0.1 | 0.1 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.1 | 0.3 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.1 | 0.5 | GO:0044331 | cell-cell adhesion mediated by cadherin(GO:0044331) |
0.1 | 0.6 | GO:0031103 | axon regeneration(GO:0031103) |
0.1 | 0.3 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.1 | 0.4 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.1 | 0.4 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
0.1 | 0.5 | GO:0002230 | positive regulation of defense response to virus by host(GO:0002230) |
0.1 | 0.1 | GO:0002765 | immune response-inhibiting signal transduction(GO:0002765) |
0.1 | 0.2 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.1 | 0.1 | GO:0051531 | NFAT protein import into nucleus(GO:0051531) |
0.1 | 1.9 | GO:0046330 | positive regulation of JNK cascade(GO:0046330) |
0.1 | 0.2 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
0.1 | 0.1 | GO:1902262 | apoptotic process involved in patterning of blood vessels(GO:1902262) |
0.1 | 0.2 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.1 | 0.1 | GO:0006555 | methionine metabolic process(GO:0006555) |
0.1 | 0.2 | GO:0015816 | glycine transport(GO:0015816) |
0.1 | 0.2 | GO:2000209 | regulation of anoikis(GO:2000209) |
0.1 | 0.1 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.1 | 0.1 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.1 | 0.2 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
0.1 | 0.2 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.1 | 0.9 | GO:0034308 | primary alcohol metabolic process(GO:0034308) |
0.1 | 0.2 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.1 | 0.4 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.1 | 0.6 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.1 | 0.3 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.1 | 0.2 | GO:0000429 | carbon catabolite regulation of transcription from RNA polymerase II promoter(GO:0000429) regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) carbon catabolite activation of transcription from RNA polymerase II promoter(GO:0000436) |
0.1 | 1.4 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.1 | 0.2 | GO:1903671 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) negative regulation of sprouting angiogenesis(GO:1903671) |
0.1 | 0.1 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.1 | 0.2 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.1 | 0.8 | GO:0001912 | positive regulation of leukocyte mediated cytotoxicity(GO:0001912) |
0.1 | 0.4 | GO:0014002 | astrocyte development(GO:0014002) |
0.1 | 0.6 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.1 | 0.1 | GO:0045076 | regulation of interleukin-2 biosynthetic process(GO:0045076) |
0.1 | 0.2 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.1 | 4.3 | GO:0006302 | double-strand break repair(GO:0006302) |
0.1 | 0.1 | GO:0097476 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
0.1 | 0.1 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.1 | 0.2 | GO:0044821 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.1 | 0.3 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.1 | 0.2 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.1 | 0.2 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.1 | 14.3 | GO:0006397 | mRNA processing(GO:0006397) |
0.1 | 0.1 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.1 | 0.9 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.1 | 0.1 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.1 | 0.2 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.1 | 0.1 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.1 | 0.1 | GO:1901298 | regulation of hydrogen peroxide-mediated programmed cell death(GO:1901298) |
0.1 | 0.1 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.1 | 0.3 | GO:0051931 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
0.1 | 0.1 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.1 | 0.1 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
0.1 | 0.1 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.1 | 4.3 | GO:0006457 | protein folding(GO:0006457) |
0.1 | 0.3 | GO:0001553 | luteinization(GO:0001553) |
0.1 | 0.1 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.1 | 0.1 | GO:0060460 | left lung morphogenesis(GO:0060460) |
0.1 | 0.2 | GO:0007000 | nucleolus organization(GO:0007000) |
0.1 | 0.1 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.1 | 0.1 | GO:0060332 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.1 | 0.2 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.1 | 0.2 | GO:0001990 | regulation of systemic arterial blood pressure by hormone(GO:0001990) |
0.1 | 0.1 | GO:0033278 | cell proliferation in midbrain(GO:0033278) |
0.1 | 0.1 | GO:2000510 | regulation of dendritic cell chemotaxis(GO:2000508) positive regulation of dendritic cell chemotaxis(GO:2000510) |
0.1 | 0.1 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.1 | 0.1 | GO:1901536 | regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
0.1 | 0.1 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.1 | 0.1 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.1 | 0.4 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
0.1 | 0.1 | GO:0071830 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
0.1 | 0.1 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.1 | 0.1 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
0.1 | 0.7 | GO:0048240 | sperm capacitation(GO:0048240) |
0.1 | 0.1 | GO:0009629 | response to gravity(GO:0009629) |
0.1 | 0.1 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.1 | 0.2 | GO:0007549 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.1 | 0.8 | GO:0000272 | polysaccharide catabolic process(GO:0000272) |
0.1 | 0.1 | GO:0031645 | negative regulation of neurological system process(GO:0031645) |
0.1 | 0.1 | GO:0045060 | negative thymic T cell selection(GO:0045060) |
0.1 | 0.1 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
0.1 | 0.3 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.0 | 0.0 | GO:0006210 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.0 | 0.0 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.0 | 0.1 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.0 | 0.1 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.0 | 0.1 | GO:0034241 | positive regulation of macrophage fusion(GO:0034241) |
0.0 | 0.1 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.0 | 0.3 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.0 | 0.1 | GO:0042559 | pteridine-containing compound biosynthetic process(GO:0042559) |
0.0 | 0.0 | GO:0010039 | response to iron ion(GO:0010039) |
0.0 | 0.1 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.0 | 0.4 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.0 | 0.0 | GO:0033033 | negative regulation of myeloid cell apoptotic process(GO:0033033) |
0.0 | 0.0 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
0.0 | 0.2 | GO:0051904 | pigment granule transport(GO:0051904) |
0.0 | 0.3 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.0 | 0.1 | GO:0032890 | regulation of organic acid transport(GO:0032890) |
0.0 | 0.0 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.0 | 0.0 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.0 | 0.1 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) |
0.0 | 0.1 | GO:0097286 | iron ion import(GO:0097286) |
0.0 | 0.0 | GO:0030204 | chondroitin sulfate metabolic process(GO:0030204) |
0.0 | 0.0 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.0 | 0.1 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.0 | 0.0 | GO:0002461 | tolerance induction dependent upon immune response(GO:0002461) |
0.0 | 0.1 | GO:0000279 | M phase(GO:0000279) |
0.0 | 0.1 | GO:0044036 | cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
0.0 | 0.0 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.0 | 0.0 | GO:0042537 | benzene-containing compound metabolic process(GO:0042537) |
0.0 | 0.1 | GO:0051549 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.0 | 0.1 | GO:0070861 | regulation of protein exit from endoplasmic reticulum(GO:0070861) |
0.0 | 0.0 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
0.0 | 0.0 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
0.0 | 0.1 | GO:0042430 | indole-containing compound metabolic process(GO:0042430) |
0.0 | 1.0 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.0 | 0.0 | GO:0065001 | specification of axis polarity(GO:0065001) |
0.0 | 0.0 | GO:0070243 | regulation of thymocyte apoptotic process(GO:0070243) |
0.0 | 0.1 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.0 | 0.0 | GO:0031652 | positive regulation of heat generation(GO:0031652) |
0.0 | 0.1 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.0 | 0.0 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.0 | 0.1 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.0 | 0.2 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.0 | 0.0 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.0 | 0.0 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.0 | 0.0 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) |
0.0 | 0.0 | GO:1903975 | regulation of glial cell migration(GO:1903975) |
0.0 | 0.0 | GO:0061355 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.0 | 0.1 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.0 | 0.1 | GO:0033198 | response to ATP(GO:0033198) |
0.0 | 0.1 | GO:0046189 | phenol-containing compound biosynthetic process(GO:0046189) |
0.0 | 0.0 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.0 | 0.0 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.0 | 0.0 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.0 | 0.0 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
0.0 | 0.1 | GO:0006544 | glycine metabolic process(GO:0006544) |
0.0 | 0.0 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.0 | 0.5 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.0 | 0.0 | GO:1900120 | regulation of receptor binding(GO:1900120) |
0.0 | 0.0 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.0 | 0.0 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.0 | 0.1 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.8 | 11.3 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
3.7 | 3.7 | GO:0043293 | apoptosome(GO:0043293) |
3.6 | 3.6 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
3.5 | 42.1 | GO:0043194 | axon initial segment(GO:0043194) |
3.4 | 10.1 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
3.2 | 3.2 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
3.0 | 9.1 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
3.0 | 8.9 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
2.8 | 19.7 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
2.8 | 8.4 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
2.8 | 11.1 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
2.8 | 11.1 | GO:0030127 | COPII vesicle coat(GO:0030127) |
2.7 | 10.7 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
2.7 | 10.6 | GO:0005955 | calcineurin complex(GO:0005955) |
2.6 | 7.8 | GO:0005899 | insulin receptor complex(GO:0005899) |
2.6 | 2.6 | GO:0031256 | leading edge membrane(GO:0031256) |
2.6 | 10.3 | GO:0009279 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
2.6 | 7.7 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
2.5 | 10.2 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
2.5 | 7.5 | GO:0036396 | MIS complex(GO:0036396) |
2.5 | 7.5 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
2.5 | 72.0 | GO:0048786 | presynaptic active zone(GO:0048786) |
2.5 | 9.9 | GO:0008091 | spectrin(GO:0008091) |
2.4 | 7.3 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
2.4 | 9.6 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
2.4 | 9.5 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
2.3 | 11.6 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) |
2.3 | 11.3 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
2.3 | 6.8 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
2.3 | 6.8 | GO:0043511 | inhibin complex(GO:0043511) |
2.3 | 9.0 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
2.2 | 6.7 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
2.2 | 8.8 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
2.2 | 6.6 | GO:0033648 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
2.2 | 6.5 | GO:0005879 | axonemal microtubule(GO:0005879) |
2.2 | 17.4 | GO:0031209 | SCAR complex(GO:0031209) |
2.1 | 8.4 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
2.0 | 24.5 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
2.0 | 27.9 | GO:0060077 | inhibitory synapse(GO:0060077) |
2.0 | 2.0 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
1.9 | 5.8 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
1.9 | 5.7 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
1.9 | 17.2 | GO:0035253 | ciliary rootlet(GO:0035253) |
1.9 | 1.9 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
1.9 | 9.3 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
1.8 | 5.5 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
1.8 | 18.4 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
1.8 | 5.4 | GO:0097451 | glial limiting end-foot(GO:0097451) |
1.8 | 8.9 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
1.8 | 1.8 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
1.8 | 12.3 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
1.7 | 6.8 | GO:0071203 | WASH complex(GO:0071203) |
1.7 | 80.7 | GO:0043198 | dendritic shaft(GO:0043198) |
1.7 | 11.7 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
1.7 | 24.9 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
1.7 | 6.6 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
1.6 | 8.2 | GO:0033503 | HULC complex(GO:0033503) |
1.6 | 9.9 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
1.6 | 4.9 | GO:0031417 | NatC complex(GO:0031417) |
1.6 | 3.2 | GO:0044308 | axonal spine(GO:0044308) |
1.6 | 9.7 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
1.6 | 9.6 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
1.6 | 4.8 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
1.6 | 34.8 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
1.6 | 7.9 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
1.6 | 1.6 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
1.5 | 9.3 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
1.5 | 9.0 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
1.5 | 4.5 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
1.5 | 8.9 | GO:0032009 | early phagosome(GO:0032009) |
1.5 | 5.9 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
1.5 | 7.4 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
1.5 | 5.9 | GO:0032591 | dendritic spine membrane(GO:0032591) |
1.5 | 4.4 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
1.4 | 1.4 | GO:0097513 | myosin II filament(GO:0097513) |
1.4 | 13.0 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
1.4 | 5.7 | GO:0043202 | lysosomal lumen(GO:0043202) |
1.4 | 1.4 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
1.4 | 11.3 | GO:0042788 | polysomal ribosome(GO:0042788) |
1.4 | 5.6 | GO:0071797 | LUBAC complex(GO:0071797) |
1.4 | 7.0 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
1.4 | 2.8 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
1.4 | 13.6 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
1.4 | 8.1 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
1.4 | 6.8 | GO:0071565 | nBAF complex(GO:0071565) |
1.3 | 6.7 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
1.3 | 5.4 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
1.3 | 8.0 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
1.3 | 6.5 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
1.3 | 10.3 | GO:0071437 | invadopodium(GO:0071437) |
1.3 | 1.3 | GO:0032133 | chromosome passenger complex(GO:0032133) |
1.3 | 7.7 | GO:0031258 | lamellipodium membrane(GO:0031258) |
1.3 | 6.3 | GO:0097433 | dense body(GO:0097433) |
1.3 | 3.8 | GO:0071942 | XPC complex(GO:0071942) |
1.3 | 5.1 | GO:0070545 | PeBoW complex(GO:0070545) |
1.3 | 1.3 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
1.3 | 12.5 | GO:0072546 | ER membrane protein complex(GO:0072546) |
1.3 | 2.5 | GO:0016600 | flotillin complex(GO:0016600) |
1.3 | 2.5 | GO:0033010 | paranodal junction(GO:0033010) |
1.2 | 8.7 | GO:0051286 | cell tip(GO:0051286) |
1.2 | 6.2 | GO:0001674 | female germ cell nucleus(GO:0001674) |
1.2 | 14.9 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
1.2 | 9.9 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
1.2 | 6.1 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
1.2 | 3.7 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
1.2 | 3.7 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
1.2 | 6.1 | GO:0097449 | astrocyte projection(GO:0097449) |
1.2 | 13.4 | GO:0042555 | MCM complex(GO:0042555) |
1.2 | 21.6 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
1.2 | 8.4 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
1.2 | 8.4 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
1.2 | 5.9 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
1.2 | 4.7 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
1.2 | 1.2 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
1.1 | 5.7 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
1.1 | 2.3 | GO:0044326 | dendritic spine neck(GO:0044326) |
1.1 | 4.6 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
1.1 | 6.8 | GO:0016011 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
1.1 | 1.1 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
1.1 | 7.9 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
1.1 | 12.3 | GO:0071564 | npBAF complex(GO:0071564) |
1.1 | 7.8 | GO:0043083 | synaptic cleft(GO:0043083) |
1.1 | 6.6 | GO:0000796 | condensin complex(GO:0000796) |
1.1 | 11.0 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
1.1 | 3.3 | GO:0032806 | carboxy-terminal domain protein kinase complex(GO:0032806) |
1.1 | 20.7 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
1.1 | 3.3 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
1.1 | 2.2 | GO:0030897 | HOPS complex(GO:0030897) |
1.1 | 8.7 | GO:0005839 | proteasome core complex(GO:0005839) |
1.1 | 3.2 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
1.1 | 41.0 | GO:0031201 | SNARE complex(GO:0031201) |
1.1 | 7.5 | GO:0042405 | nuclear inclusion body(GO:0042405) |
1.1 | 15.9 | GO:0030904 | retromer complex(GO:0030904) |
1.1 | 8.4 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
1.0 | 6.3 | GO:0032584 | growth cone membrane(GO:0032584) |
1.0 | 5.2 | GO:0000235 | astral microtubule(GO:0000235) |
1.0 | 1.0 | GO:0097149 | centralspindlin complex(GO:0097149) |
1.0 | 2.1 | GO:0044316 | cone cell pedicle(GO:0044316) |
1.0 | 8.2 | GO:0032300 | mismatch repair complex(GO:0032300) |
1.0 | 4.1 | GO:0031983 | vesicle lumen(GO:0031983) |
1.0 | 3.1 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
1.0 | 3.1 | GO:0005726 | perichromatin fibrils(GO:0005726) |
1.0 | 1.0 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
1.0 | 3.0 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
1.0 | 4.0 | GO:0033269 | internode region of axon(GO:0033269) |
1.0 | 60.2 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
1.0 | 3.0 | GO:0031262 | Ndc80 complex(GO:0031262) |
1.0 | 4.0 | GO:0000938 | GARP complex(GO:0000938) |
1.0 | 3.9 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
1.0 | 5.8 | GO:0071986 | Ragulator complex(GO:0071986) |
1.0 | 3.8 | GO:0032433 | filopodium tip(GO:0032433) |
1.0 | 1.9 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
1.0 | 7.7 | GO:0070652 | HAUS complex(GO:0070652) |
1.0 | 7.6 | GO:0031082 | BLOC complex(GO:0031082) |
1.0 | 5.7 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.9 | 9.4 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.9 | 8.4 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.9 | 6.6 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.9 | 3.7 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.9 | 3.7 | GO:0070876 | SOSS complex(GO:0070876) |
0.9 | 2.7 | GO:0045171 | intercellular bridge(GO:0045171) |
0.9 | 8.2 | GO:0000124 | SAGA complex(GO:0000124) |
0.9 | 1.8 | GO:0033263 | CORVET complex(GO:0033263) |
0.9 | 23.7 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.9 | 19.1 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.9 | 6.3 | GO:0030677 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.9 | 2.7 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.9 | 36.8 | GO:0044309 | neuron spine(GO:0044309) |
0.9 | 2.7 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.9 | 3.5 | GO:0031261 | DNA replication preinitiation complex(GO:0031261) |
0.9 | 10.6 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.9 | 6.1 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.9 | 11.4 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.9 | 2.6 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.9 | 6.1 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.9 | 4.4 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.9 | 6.1 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.9 | 11.2 | GO:0001891 | phagocytic cup(GO:0001891) |
0.9 | 3.4 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.9 | 1.7 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.9 | 2.6 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.9 | 5.1 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.9 | 2.6 | GO:0097386 | glial cell projection(GO:0097386) |
0.9 | 2.6 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.8 | 5.1 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
0.8 | 20.1 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.8 | 0.8 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.8 | 21.6 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.8 | 2.5 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.8 | 19.9 | GO:0005776 | autophagosome(GO:0005776) |
0.8 | 1.7 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.8 | 4.1 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.8 | 8.2 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.8 | 24.5 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.8 | 2.4 | GO:0034464 | BBSome(GO:0034464) |
0.8 | 3.2 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.8 | 12.8 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
0.8 | 3.2 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
0.8 | 3.2 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.8 | 3.2 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.8 | 1.6 | GO:0070552 | BRISC complex(GO:0070552) |
0.8 | 3.1 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.8 | 123.8 | GO:0097060 | synaptic membrane(GO:0097060) |
0.8 | 3.1 | GO:0000346 | transcription export complex(GO:0000346) |
0.8 | 6.3 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.8 | 3.1 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.8 | 67.6 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.8 | 1.6 | GO:0022624 | proteasome accessory complex(GO:0022624) |
0.8 | 1.5 | GO:0030478 | actin cap(GO:0030478) |
0.8 | 2.3 | GO:0099503 | secretory vesicle(GO:0099503) |
0.8 | 4.6 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.8 | 9.9 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.8 | 3.8 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.8 | 0.8 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.7 | 2.2 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.7 | 6.7 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.7 | 4.5 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.7 | 2.9 | GO:1904949 | ATPase complex(GO:1904949) |
0.7 | 4.4 | GO:0044295 | axonal growth cone(GO:0044295) |
0.7 | 0.7 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.7 | 2.9 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.7 | 7.2 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.7 | 5.0 | GO:0005883 | neurofilament(GO:0005883) |
0.7 | 4.3 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.7 | 15.0 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.7 | 14.1 | GO:0044298 | cell body membrane(GO:0044298) |
0.7 | 7.0 | GO:0031512 | motile primary cilium(GO:0031512) |
0.7 | 24.5 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.7 | 51.1 | GO:0016607 | nuclear speck(GO:0016607) |
0.7 | 0.7 | GO:0097422 | tubular endosome(GO:0097422) |
0.7 | 2.1 | GO:0005775 | vacuolar lumen(GO:0005775) |
0.7 | 4.1 | GO:0097526 | spliceosomal tri-snRNP complex(GO:0097526) |
0.7 | 2.1 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.7 | 0.7 | GO:0097441 | basilar dendrite(GO:0097441) |
0.7 | 8.9 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.7 | 2.1 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.7 | 2.1 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.7 | 1.4 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.7 | 2.7 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.7 | 2.7 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.7 | 4.7 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.7 | 15.6 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.7 | 2.7 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.7 | 2.0 | GO:0005687 | U4 snRNP(GO:0005687) |
0.7 | 6.0 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.7 | 15.4 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.7 | 11.4 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.7 | 28.0 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.7 | 3.3 | GO:0000805 | X chromosome(GO:0000805) |
0.7 | 2.7 | GO:1990246 | uniplex complex(GO:1990246) |
0.7 | 4.6 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.7 | 5.3 | GO:0005869 | dynactin complex(GO:0005869) |
0.7 | 2.6 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.7 | 3.3 | GO:0005688 | U6 snRNP(GO:0005688) |
0.7 | 13.7 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.7 | 15.0 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.7 | 12.4 | GO:0035861 | site of double-strand break(GO:0035861) |
0.6 | 3.9 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.6 | 2.6 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.6 | 3.2 | GO:0002177 | manchette(GO:0002177) |
0.6 | 5.1 | GO:0036156 | inner dynein arm(GO:0036156) |
0.6 | 0.6 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.6 | 5.1 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.6 | 3.8 | GO:0042587 | glycogen granule(GO:0042587) |
0.6 | 25.9 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.6 | 24.7 | GO:0030964 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.6 | 1.9 | GO:0000125 | PCAF complex(GO:0000125) |
0.6 | 2.5 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.6 | 0.6 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.6 | 0.6 | GO:0055087 | Ski complex(GO:0055087) |
0.6 | 1.9 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.6 | 5.6 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.6 | 1.9 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.6 | 3.1 | GO:0000812 | Swr1 complex(GO:0000812) |
0.6 | 9.2 | GO:0010369 | chromocenter(GO:0010369) |
0.6 | 20.2 | GO:0016592 | mediator complex(GO:0016592) |
0.6 | 0.6 | GO:1990745 | EARP complex(GO:1990745) |
0.6 | 2.4 | GO:0031429 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) |
0.6 | 5.3 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.6 | 1.2 | GO:0097546 | ciliary base(GO:0097546) |
0.6 | 25.8 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.6 | 15.7 | GO:0032040 | small-subunit processome(GO:0032040) |
0.6 | 2.9 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.6 | 36.9 | GO:0055037 | recycling endosome(GO:0055037) |
0.6 | 23.1 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.6 | 4.6 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.6 | 11.4 | GO:0070469 | respiratory chain(GO:0070469) |
0.6 | 5.7 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.6 | 3.9 | GO:0016272 | prefoldin complex(GO:0016272) |
0.6 | 4.5 | GO:0030027 | lamellipodium(GO:0030027) |
0.6 | 7.9 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.6 | 6.2 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.6 | 6.7 | GO:0070822 | Sin3-type complex(GO:0070822) |
0.6 | 7.2 | GO:0000145 | exocyst(GO:0000145) |
0.6 | 3.3 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
0.6 | 5.0 | GO:0000800 | lateral element(GO:0000800) |
0.6 | 5.0 | GO:0008287 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.5 | 14.7 | GO:0099572 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
0.5 | 13.6 | GO:0044439 | microbody part(GO:0044438) peroxisomal part(GO:0044439) |
0.5 | 2.7 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.5 | 1.1 | GO:0016528 | sarcoplasm(GO:0016528) |
0.5 | 8.1 | GO:0070382 | exocytic vesicle(GO:0070382) |
0.5 | 0.5 | GO:0043219 | lateral loop(GO:0043219) |
0.5 | 13.4 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.5 | 2.1 | GO:0034704 | calcium channel complex(GO:0034704) |
0.5 | 8.3 | GO:0005876 | spindle microtubule(GO:0005876) |
0.5 | 2.6 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.5 | 30.4 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.5 | 2.1 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.5 | 1.5 | GO:1990696 | USH2 complex(GO:1990696) |
0.5 | 5.6 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.5 | 7.7 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
0.5 | 5.1 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.5 | 1.0 | GO:0032437 | cuticular plate(GO:0032437) |
0.5 | 6.1 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.5 | 3.0 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.5 | 23.7 | GO:0034705 | potassium channel complex(GO:0034705) |
0.5 | 2.0 | GO:0005902 | microvillus(GO:0005902) |
0.5 | 4.5 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.5 | 132.1 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.5 | 7.9 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.5 | 1.5 | GO:0005675 | holo TFIIH complex(GO:0005675) |
0.5 | 3.0 | GO:1902555 | endoribonuclease complex(GO:1902555) |
0.5 | 0.5 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.5 | 3.4 | GO:0097440 | apical dendrite(GO:0097440) |
0.5 | 13.7 | GO:0016234 | inclusion body(GO:0016234) |
0.5 | 19.9 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.5 | 3.9 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.5 | 0.5 | GO:0015934 | large ribosomal subunit(GO:0015934) |
0.5 | 4.8 | GO:0032039 | integrator complex(GO:0032039) |
0.5 | 1.4 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.5 | 1.4 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.5 | 17.4 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.5 | 1.4 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.5 | 4.2 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
0.5 | 1.8 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.5 | 2.8 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.5 | 47.0 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.5 | 1.8 | GO:0030686 | 90S preribosome(GO:0030686) |
0.5 | 2.7 | GO:0030008 | TRAPP complex(GO:0030008) |
0.5 | 2.3 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.4 | 1.8 | GO:0031526 | brush border membrane(GO:0031526) |
0.4 | 3.1 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.4 | 6.2 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.4 | 4.9 | GO:0038201 | TOR complex(GO:0038201) |
0.4 | 0.9 | GO:0072534 | perineuronal net(GO:0072534) |
0.4 | 17.1 | GO:0005643 | nuclear pore(GO:0005643) |
0.4 | 5.7 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.4 | 1.3 | GO:0048475 | membrane coat(GO:0030117) coated membrane(GO:0048475) |
0.4 | 3.4 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.4 | 15.0 | GO:0044291 | cell-cell contact zone(GO:0044291) |
0.4 | 3.9 | GO:1990391 | DNA repair complex(GO:1990391) |
0.4 | 19.7 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.4 | 4.6 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.4 | 0.4 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.4 | 135.3 | GO:0005813 | centrosome(GO:0005813) |
0.4 | 0.4 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.4 | 6.2 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.4 | 26.9 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.4 | 31.7 | GO:0005770 | late endosome(GO:0005770) |
0.4 | 0.4 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.4 | 12.7 | GO:0032587 | ruffle membrane(GO:0032587) |
0.4 | 1.6 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.4 | 0.8 | GO:0042641 | actomyosin(GO:0042641) |
0.4 | 1.6 | GO:0035859 | Seh1-associated complex(GO:0035859) Iml1 complex(GO:1990130) |
0.4 | 1.2 | GO:0031970 | organelle envelope lumen(GO:0031970) |
0.4 | 3.9 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.4 | 4.2 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.4 | 391.9 | GO:0005739 | mitochondrion(GO:0005739) |
0.4 | 0.7 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.4 | 13.6 | GO:0000776 | kinetochore(GO:0000776) |
0.4 | 17.8 | GO:0043209 | myelin sheath(GO:0043209) |
0.4 | 1.8 | GO:0016589 | NURF complex(GO:0016589) |
0.4 | 9.4 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
0.4 | 13.9 | GO:0001726 | ruffle(GO:0001726) |
0.3 | 0.3 | GO:0090543 | Flemming body(GO:0090543) |
0.3 | 2.1 | GO:0072562 | blood microparticle(GO:0072562) |
0.3 | 2.1 | GO:0070187 | telosome(GO:0070187) |
0.3 | 2.4 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.3 | 1.4 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
0.3 | 0.7 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.3 | 0.3 | GO:0043196 | varicosity(GO:0043196) |
0.3 | 0.3 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.3 | 30.5 | GO:0000139 | Golgi membrane(GO:0000139) |
0.3 | 6.8 | GO:0030133 | transport vesicle(GO:0030133) |
0.3 | 0.3 | GO:0097255 | R2TP complex(GO:0097255) |
0.3 | 65.8 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.3 | 3.4 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.3 | 2.2 | GO:0005773 | vacuole(GO:0005773) |
0.3 | 8.0 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.3 | 1.2 | GO:0008278 | cohesin complex(GO:0008278) |
0.3 | 3.9 | GO:0015030 | Cajal body(GO:0015030) |
0.3 | 3.3 | GO:0045120 | pronucleus(GO:0045120) |
0.3 | 1.7 | GO:1902562 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.3 | 1.7 | GO:0042611 | MHC protein complex(GO:0042611) |
0.3 | 19.0 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.3 | 7.1 | GO:0005921 | gap junction(GO:0005921) |
0.3 | 15.2 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
0.3 | 7.8 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.3 | 2.4 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.3 | 2.1 | GO:0016023 | cytoplasmic, membrane-bounded vesicle(GO:0016023) |
0.3 | 8.7 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.2 | 0.5 | GO:0031224 | intrinsic component of membrane(GO:0031224) |
0.2 | 10.3 | GO:0005840 | ribosome(GO:0005840) |
0.2 | 137.2 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.2 | 1.4 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.2 | 0.7 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.2 | 6.0 | GO:0030427 | site of polarized growth(GO:0030427) |
0.2 | 0.2 | GO:0042567 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.2 | 14.5 | GO:0045202 | synapse(GO:0045202) |
0.2 | 0.2 | GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
0.2 | 82.7 | GO:0005794 | Golgi apparatus(GO:0005794) |
0.2 | 0.6 | GO:0060076 | excitatory synapse(GO:0060076) |
0.2 | 0.2 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.2 | 1.4 | GO:0033391 | chromatoid body(GO:0033391) |
0.2 | 0.6 | GO:0042382 | paraspeckles(GO:0042382) |
0.2 | 0.9 | GO:0030990 | intraciliary transport particle(GO:0030990) |
0.2 | 2.9 | GO:0030175 | filopodium(GO:0030175) |
0.2 | 0.5 | GO:0060091 | kinocilium(GO:0060091) |
0.2 | 0.2 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.2 | 0.7 | GO:0032021 | NELF complex(GO:0032021) |
0.2 | 4.5 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.2 | 2.8 | GO:0036126 | sperm flagellum(GO:0036126) |
0.2 | 13.2 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.2 | 1.1 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.1 | 13.7 | GO:0005929 | cilium(GO:0005929) |
0.1 | 495.8 | GO:0016021 | integral component of membrane(GO:0016021) |
0.1 | 0.3 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.1 | 1.6 | GO:0005635 | nuclear envelope(GO:0005635) |
0.1 | 1.1 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.1 | 0.1 | GO:0061574 | ASAP complex(GO:0061574) |
0.1 | 1.3 | GO:0044306 | neuron projection terminus(GO:0044306) |
0.1 | 0.1 | GO:0032838 | cell projection cytoplasm(GO:0032838) |
0.1 | 2.0 | GO:0098562 | cytoplasmic side of membrane(GO:0098562) |
0.1 | 0.5 | GO:0098858 | actin-based cell projection(GO:0098858) |
0.1 | 1.3 | GO:0005911 | cell-cell junction(GO:0005911) |
0.1 | 0.3 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.1 | 1.7 | GO:0016604 | nuclear body(GO:0016604) |
0.1 | 0.1 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.1 | 2.1 | GO:0005903 | brush border(GO:0005903) |
0.1 | 0.1 | GO:0097342 | ripoptosome(GO:0097342) |
0.1 | 1.3 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 6.8 | GO:0012505 | endomembrane system(GO:0012505) |
0.1 | 2.4 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.1 | 0.9 | GO:0005657 | replication fork(GO:0005657) |
0.1 | 0.2 | GO:0097346 | INO80-type complex(GO:0097346) |
0.1 | 0.2 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.1 | 48.3 | GO:0070062 | extracellular exosome(GO:0070062) |
0.1 | 0.1 | GO:0044215 | other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.1 | 1.4 | GO:0032994 | protein-lipid complex(GO:0032994) plasma lipoprotein particle(GO:0034358) lipoprotein particle(GO:1990777) |
0.1 | 1.2 | GO:0044445 | cytosolic part(GO:0044445) |
0.1 | 67.0 | GO:0016020 | membrane(GO:0016020) |
0.1 | 7.3 | GO:0015630 | microtubule cytoskeleton(GO:0015630) |
0.1 | 0.1 | GO:0045177 | apical part of cell(GO:0045177) |
0.1 | 0.1 | GO:0005605 | basal lamina(GO:0005605) |
0.1 | 0.1 | GO:0001739 | sex chromatin(GO:0001739) |
0.1 | 0.1 | GO:0031523 | Myb complex(GO:0031523) |
0.0 | 0.2 | GO:0032797 | SMN complex(GO:0032797) |
0.0 | 0.1 | GO:0001741 | XY body(GO:0001741) |
0.0 | 0.1 | GO:0000791 | euchromatin(GO:0000791) |
0.0 | 0.0 | GO:1990923 | PET complex(GO:1990923) |
0.0 | 0.1 | GO:0043073 | male germ cell nucleus(GO:0001673) germ cell nucleus(GO:0043073) |
0.0 | 0.0 | GO:0070695 | FHF complex(GO:0070695) |
0.0 | 0.1 | GO:1902554 | serine/threonine protein kinase complex(GO:1902554) |
0.0 | 0.0 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.0 | 30.5 | GO:0005737 | cytoplasm(GO:0005737) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.1 | 18.2 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
4.2 | 12.6 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
4.1 | 12.2 | GO:0050816 | phosphothreonine binding(GO:0050816) |
3.9 | 19.6 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
3.9 | 23.2 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
3.8 | 11.4 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
3.6 | 10.8 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
3.6 | 10.7 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
3.5 | 10.6 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
3.5 | 10.6 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
3.5 | 17.3 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
3.3 | 13.4 | GO:0050693 | LBD domain binding(GO:0050693) |
3.3 | 9.9 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
3.2 | 9.5 | GO:0036033 | mediator complex binding(GO:0036033) |
3.1 | 9.4 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
3.1 | 9.2 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
3.0 | 9.1 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
3.0 | 8.9 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
2.9 | 11.7 | GO:0005042 | netrin receptor activity(GO:0005042) |
2.9 | 5.8 | GO:0090079 | translation activator activity(GO:0008494) translation regulator activity, nucleic acid binding(GO:0090079) |
2.9 | 8.6 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
2.8 | 8.5 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
2.8 | 8.5 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
2.8 | 8.3 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
2.7 | 10.9 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
2.7 | 8.1 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
2.7 | 13.3 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
2.7 | 8.0 | GO:0070699 | type II activin receptor binding(GO:0070699) |
2.6 | 10.5 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
2.6 | 7.9 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
2.6 | 7.8 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
2.6 | 7.8 | GO:1990460 | leptin receptor binding(GO:1990460) |
2.5 | 12.6 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
2.5 | 12.4 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
2.4 | 7.3 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
2.4 | 7.3 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
2.4 | 14.5 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
2.4 | 19.3 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
2.4 | 7.2 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
2.4 | 7.1 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
2.3 | 9.4 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
2.3 | 7.0 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
2.3 | 6.9 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
2.3 | 27.4 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
2.2 | 6.6 | GO:0032142 | single guanine insertion binding(GO:0032142) |
2.2 | 6.5 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
2.2 | 4.3 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
2.2 | 10.8 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
2.2 | 28.1 | GO:0050811 | GABA receptor binding(GO:0050811) |
2.2 | 4.3 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
2.1 | 8.6 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
2.1 | 8.6 | GO:0052833 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
2.1 | 6.4 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
2.1 | 6.3 | GO:0008948 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) oxaloacetate decarboxylase activity(GO:0008948) |
2.1 | 4.1 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
2.1 | 8.2 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
2.0 | 8.2 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
2.0 | 2.0 | GO:0046921 | alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
2.0 | 7.9 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
1.9 | 15.5 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
1.9 | 7.6 | GO:0005047 | signal recognition particle binding(GO:0005047) |
1.9 | 5.6 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
1.9 | 9.3 | GO:0030957 | Tat protein binding(GO:0030957) |
1.9 | 5.6 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
1.8 | 11.1 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
1.8 | 14.8 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
1.8 | 5.4 | GO:0009041 | uridylate kinase activity(GO:0009041) |
1.8 | 5.4 | GO:0097016 | L27 domain binding(GO:0097016) |
1.8 | 5.4 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
1.8 | 9.0 | GO:0070728 | leucine binding(GO:0070728) |
1.8 | 7.1 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
1.7 | 8.7 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
1.7 | 1.7 | GO:0016429 | tRNA (adenine) methyltransferase activity(GO:0016426) tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
1.7 | 5.1 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
1.7 | 6.8 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
1.7 | 1.7 | GO:0008579 | JUN kinase phosphatase activity(GO:0008579) |
1.7 | 3.3 | GO:0044390 | ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
1.6 | 4.9 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
1.6 | 4.9 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
1.6 | 6.5 | GO:1904288 | BAT3 complex binding(GO:1904288) |
1.6 | 6.5 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
1.6 | 8.1 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
1.6 | 16.0 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
1.6 | 4.8 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
1.6 | 12.7 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
1.6 | 20.4 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
1.6 | 14.1 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
1.5 | 7.7 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
1.5 | 4.6 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
1.5 | 10.8 | GO:0102338 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
1.5 | 9.1 | GO:0016004 | phospholipase activator activity(GO:0016004) |
1.5 | 3.0 | GO:1990188 | euchromatin binding(GO:1990188) |
1.5 | 7.5 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
1.5 | 7.5 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
1.5 | 4.5 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
1.5 | 6.0 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
1.5 | 1.5 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) |
1.5 | 20.8 | GO:0045295 | gamma-catenin binding(GO:0045295) |
1.5 | 4.4 | GO:0030350 | iron-responsive element binding(GO:0030350) |
1.5 | 1.5 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
1.5 | 5.9 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
1.5 | 4.4 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
1.5 | 5.8 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
1.4 | 41.8 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
1.4 | 2.9 | GO:0045503 | dynein light chain binding(GO:0045503) |
1.4 | 1.4 | GO:0030284 | estrogen receptor activity(GO:0030284) |
1.4 | 4.3 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
1.4 | 5.7 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
1.4 | 12.9 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
1.4 | 41.5 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
1.4 | 12.9 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
1.4 | 2.8 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
1.4 | 4.2 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
1.4 | 4.2 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
1.4 | 5.6 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
1.4 | 15.5 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
1.4 | 28.2 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
1.4 | 5.6 | GO:0019808 | polyamine binding(GO:0019808) |
1.4 | 4.2 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
1.4 | 2.8 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
1.4 | 15.5 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
1.4 | 22.3 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
1.4 | 2.8 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
1.4 | 4.2 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
1.4 | 5.5 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
1.4 | 5.5 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
1.4 | 39.9 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
1.4 | 5.5 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
1.4 | 1.4 | GO:0046870 | cadmium ion binding(GO:0046870) |
1.4 | 11.0 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
1.4 | 5.5 | GO:0070878 | primary miRNA binding(GO:0070878) |
1.4 | 9.5 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
1.4 | 10.9 | GO:0017070 | U6 snRNA binding(GO:0017070) |
1.4 | 6.8 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
1.4 | 4.1 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
1.4 | 4.1 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
1.3 | 5.4 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
1.3 | 6.7 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
1.3 | 8.0 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
1.3 | 4.0 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
1.3 | 5.3 | GO:0050897 | cobalt ion binding(GO:0050897) |
1.3 | 4.0 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
1.3 | 2.6 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
1.3 | 2.6 | GO:0043398 | HLH domain binding(GO:0043398) |
1.3 | 6.6 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
1.3 | 3.9 | GO:0015182 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
1.3 | 9.1 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
1.3 | 7.8 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
1.3 | 3.9 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
1.3 | 5.2 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
1.3 | 14.3 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
1.3 | 11.6 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
1.3 | 18.0 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
1.3 | 9.0 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
1.3 | 1.3 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
1.3 | 5.1 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
1.3 | 5.1 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
1.3 | 7.6 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
1.3 | 3.8 | GO:1901612 | cardiolipin binding(GO:1901612) |
1.3 | 3.8 | GO:0030984 | kininogen binding(GO:0030984) |
1.3 | 3.8 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
1.2 | 20.0 | GO:0022840 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
1.2 | 3.7 | GO:2001070 | starch binding(GO:2001070) |
1.2 | 3.7 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
1.2 | 6.2 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
1.2 | 18.5 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
1.2 | 8.6 | GO:0035197 | siRNA binding(GO:0035197) |
1.2 | 6.1 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
1.2 | 8.6 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
1.2 | 11.0 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
1.2 | 25.8 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
1.2 | 4.9 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
1.2 | 2.4 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
1.2 | 4.9 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
1.2 | 3.7 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
1.2 | 4.9 | GO:0046923 | ER retention sequence binding(GO:0046923) |
1.2 | 3.7 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
1.2 | 3.6 | GO:0016212 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
1.2 | 1.2 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
1.2 | 3.6 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
1.2 | 1.2 | GO:0008169 | C-methyltransferase activity(GO:0008169) 2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity(GO:0008425) quinone cofactor methyltransferase activity(GO:0030580) |
1.2 | 12.1 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
1.2 | 3.6 | GO:0008312 | 7S RNA binding(GO:0008312) |
1.2 | 10.8 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
1.2 | 6.0 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
1.2 | 4.8 | GO:0032051 | clathrin light chain binding(GO:0032051) |
1.2 | 4.8 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
1.2 | 8.4 | GO:0003688 | DNA replication origin binding(GO:0003688) |
1.2 | 3.6 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
1.2 | 2.4 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
1.2 | 1.2 | GO:0016595 | glutamate binding(GO:0016595) |
1.2 | 2.4 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
1.2 | 3.6 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
1.2 | 15.3 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
1.2 | 15.3 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
1.2 | 5.8 | GO:0034416 | bisphosphoglycerate phosphatase activity(GO:0034416) |
1.2 | 1.2 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
1.2 | 1.2 | GO:0001884 | pyrimidine nucleoside binding(GO:0001884) |
1.2 | 5.8 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
1.1 | 27.6 | GO:0044688 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
1.1 | 1.1 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
1.1 | 4.6 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
1.1 | 1.1 | GO:0001098 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
1.1 | 7.9 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
1.1 | 3.4 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
1.1 | 6.8 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
1.1 | 5.6 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
1.1 | 16.7 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
1.1 | 14.4 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
1.1 | 2.2 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
1.1 | 3.3 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
1.1 | 9.9 | GO:0015172 | L-glutamate transmembrane transporter activity(GO:0005313) acidic amino acid transmembrane transporter activity(GO:0015172) |
1.1 | 13.2 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
1.1 | 4.4 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
1.1 | 5.5 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
1.1 | 2.2 | GO:0045340 | mercury ion binding(GO:0045340) |
1.1 | 4.4 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
1.1 | 4.3 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
1.1 | 21.6 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
1.1 | 5.4 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
1.1 | 20.5 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
1.1 | 65.7 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
1.1 | 10.6 | GO:0042043 | neurexin family protein binding(GO:0042043) |
1.1 | 9.6 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
1.1 | 5.3 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
1.1 | 5.3 | GO:0008410 | CoA-transferase activity(GO:0008410) |
1.1 | 1.1 | GO:0035473 | lipase binding(GO:0035473) |
1.1 | 3.2 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
1.1 | 2.1 | GO:2001069 | glycogen binding(GO:2001069) |
1.1 | 3.2 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
1.1 | 2.1 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
1.1 | 4.2 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
1.0 | 3.1 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
1.0 | 1.0 | GO:0035870 | dITP diphosphatase activity(GO:0035870) XTP diphosphatase activity(GO:0036222) |
1.0 | 9.4 | GO:0031386 | protein tag(GO:0031386) |
1.0 | 3.1 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
1.0 | 1.0 | GO:0018423 | protein C-terminal leucine carboxyl O-methyltransferase activity(GO:0018423) |
1.0 | 7.3 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
1.0 | 4.2 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
1.0 | 5.2 | GO:0016893 | endoribonuclease activity, producing 5'-phosphomonoesters(GO:0016891) endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters(GO:0016893) |
1.0 | 4.2 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
1.0 | 3.1 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
1.0 | 7.2 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
1.0 | 11.3 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
1.0 | 3.1 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
1.0 | 14.3 | GO:0031402 | sodium ion binding(GO:0031402) |
1.0 | 6.1 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
1.0 | 4.1 | GO:0043559 | insulin binding(GO:0043559) |
1.0 | 16.2 | GO:0003785 | actin monomer binding(GO:0003785) |
1.0 | 4.0 | GO:0102345 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
1.0 | 27.3 | GO:0005484 | SNAP receptor activity(GO:0005484) |
1.0 | 2.0 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
1.0 | 9.0 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
1.0 | 10.0 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
1.0 | 9.0 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
1.0 | 1.0 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
1.0 | 5.0 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
1.0 | 4.9 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
1.0 | 1.0 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
1.0 | 20.7 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
1.0 | 2.9 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
1.0 | 8.8 | GO:0016215 | acyl-CoA desaturase activity(GO:0016215) |
1.0 | 1.9 | GO:0032564 | dATP binding(GO:0032564) |
1.0 | 2.9 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
1.0 | 1.0 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
1.0 | 2.9 | GO:0016151 | nickel cation binding(GO:0016151) |
1.0 | 4.8 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
1.0 | 4.8 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
1.0 | 10.6 | GO:0019215 | intermediate filament binding(GO:0019215) |
1.0 | 3.8 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
1.0 | 19.1 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
0.9 | 41.8 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.9 | 4.7 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.9 | 15.1 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.9 | 2.8 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.9 | 2.8 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.9 | 8.4 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.9 | 3.7 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.9 | 2.8 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.9 | 5.6 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.9 | 11.1 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.9 | 4.6 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.9 | 0.9 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.9 | 10.2 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.9 | 5.5 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.9 | 4.6 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.9 | 1.8 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.9 | 10.0 | GO:0016594 | glycine binding(GO:0016594) |
0.9 | 5.5 | GO:0004661 | protein geranylgeranyltransferase activity(GO:0004661) |
0.9 | 2.7 | GO:0070840 | dynein complex binding(GO:0070840) |
0.9 | 3.6 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.9 | 1.8 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.9 | 4.5 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.9 | 10.8 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.9 | 3.6 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.9 | 4.5 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.9 | 1.8 | GO:0071253 | connexin binding(GO:0071253) |
0.9 | 3.6 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.9 | 2.7 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.9 | 45.9 | GO:0019003 | GDP binding(GO:0019003) |
0.9 | 4.4 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.9 | 3.5 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.9 | 3.5 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.9 | 2.6 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.9 | 11.4 | GO:0030275 | LRR domain binding(GO:0030275) |
0.9 | 2.6 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.9 | 0.9 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.9 | 4.3 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.9 | 2.6 | GO:0008443 | phosphofructokinase activity(GO:0008443) |
0.9 | 4.3 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.9 | 3.4 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.9 | 6.0 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.8 | 1.7 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.8 | 3.4 | GO:0043515 | kinetochore binding(GO:0043515) |
0.8 | 11.0 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.8 | 5.9 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.8 | 1.7 | GO:0030274 | LIM domain binding(GO:0030274) |
0.8 | 14.4 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.8 | 2.5 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.8 | 1.7 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.8 | 3.4 | GO:0032557 | pyrimidine ribonucleotide binding(GO:0032557) |
0.8 | 3.4 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.8 | 3.4 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.8 | 5.0 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.8 | 5.0 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.8 | 0.8 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.8 | 2.5 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.8 | 3.3 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.8 | 3.3 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.8 | 4.2 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.8 | 1.6 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.8 | 1.6 | GO:0097001 | ceramide binding(GO:0097001) |
0.8 | 2.4 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.8 | 2.4 | GO:0055100 | adiponectin binding(GO:0055100) |
0.8 | 0.8 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.8 | 4.0 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.8 | 20.2 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.8 | 2.4 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.8 | 13.4 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.8 | 5.5 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.8 | 2.4 | GO:0019961 | interferon binding(GO:0019961) |
0.8 | 1.6 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.8 | 2.3 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.8 | 1.6 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.8 | 16.4 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.8 | 3.1 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.8 | 30.4 | GO:0043022 | ribosome binding(GO:0043022) |
0.8 | 2.3 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.8 | 4.7 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.8 | 1.6 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
0.8 | 3.9 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.8 | 3.9 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
0.8 | 1.5 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.8 | 11.4 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.8 | 0.8 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.8 | 19.7 | GO:0030145 | manganese ion binding(GO:0030145) |
0.8 | 2.3 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.7 | 9.0 | GO:0003905 | alkylbase DNA N-glycosylase activity(GO:0003905) DNA-3-methylbase glycosylase activity(GO:0043733) |
0.7 | 0.7 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.7 | 0.7 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.7 | 35.1 | GO:0019208 | phosphatase regulator activity(GO:0019208) |
0.7 | 3.0 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.7 | 2.2 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.7 | 3.7 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.7 | 1.5 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.7 | 0.7 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.7 | 1.5 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.7 | 1.5 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.7 | 28.5 | GO:0000049 | tRNA binding(GO:0000049) |
0.7 | 5.1 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.7 | 6.6 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.7 | 2.2 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.7 | 4.4 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.7 | 8.0 | GO:0070402 | NADPH binding(GO:0070402) |
0.7 | 25.3 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.7 | 4.3 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.7 | 9.4 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.7 | 6.5 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.7 | 10.8 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.7 | 3.6 | GO:0043426 | MRF binding(GO:0043426) |
0.7 | 9.3 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.7 | 7.1 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.7 | 7.0 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.7 | 3.5 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.7 | 3.5 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.7 | 2.1 | GO:0008026 | ATP-dependent helicase activity(GO:0008026) purine NTP-dependent helicase activity(GO:0070035) |
0.7 | 26.4 | GO:0030276 | clathrin binding(GO:0030276) |
0.7 | 8.3 | GO:0043176 | amine binding(GO:0043176) |
0.7 | 2.1 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.7 | 3.5 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.7 | 0.7 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.7 | 2.7 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.7 | 6.9 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.7 | 2.7 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
0.7 | 3.4 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.7 | 2.1 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
0.7 | 4.7 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.7 | 2.7 | GO:0004738 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.7 | 6.7 | GO:0015266 | protein channel activity(GO:0015266) |
0.7 | 5.4 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.7 | 1.3 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.7 | 2.0 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.7 | 2.6 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.7 | 17.1 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.7 | 2.0 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.7 | 28.7 | GO:0001190 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
0.7 | 2.0 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.7 | 2.0 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.6 | 2.6 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
0.6 | 1.9 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.6 | 1.3 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.6 | 1.9 | GO:0019104 | uracil DNA N-glycosylase activity(GO:0004844) DNA N-glycosylase activity(GO:0019104) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.6 | 4.5 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.6 | 1.9 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.6 | 4.5 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.6 | 0.6 | GO:0000009 | alpha-1,6-mannosyltransferase activity(GO:0000009) |
0.6 | 0.6 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.6 | 19.1 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.6 | 1.9 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.6 | 7.5 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.6 | 3.8 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.6 | 1.9 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.6 | 12.5 | GO:0008375 | acetylglucosaminyltransferase activity(GO:0008375) |
0.6 | 0.6 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) |
0.6 | 9.2 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.6 | 1.8 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.6 | 0.6 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.6 | 1.2 | GO:0015928 | fucosidase activity(GO:0015928) |
0.6 | 1.8 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.6 | 9.7 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.6 | 3.0 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.6 | 14.5 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.6 | 3.6 | GO:0080011 | pivalyl-CoA mutase activity(GO:0034784) o-hydroxylaminobenzoate mutase activity(GO:0034951) lupeol synthase activity(GO:0042299) beta-amyrin synthase activity(GO:0042300) baruol synthase activity(GO:0080011) |
0.6 | 4.8 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.6 | 3.0 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.6 | 0.6 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
0.6 | 16.5 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.6 | 4.6 | GO:0070628 | proteasome binding(GO:0070628) |
0.6 | 0.6 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.6 | 2.3 | GO:0001164 | RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.6 | 2.9 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.6 | 2.3 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.6 | 13.8 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.6 | 2.8 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.6 | 1.1 | GO:0045182 | translation regulator activity(GO:0045182) |
0.6 | 1.1 | GO:0031420 | alkali metal ion binding(GO:0031420) |
0.6 | 4.0 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.6 | 1.7 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.6 | 3.4 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.6 | 9.0 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.6 | 19.1 | GO:0000149 | SNARE binding(GO:0000149) |
0.6 | 5.6 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.6 | 0.6 | GO:0032135 | DNA insertion or deletion binding(GO:0032135) |
0.6 | 10.0 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.6 | 15.5 | GO:0016875 | ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.6 | 1.7 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.6 | 6.1 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.6 | 1.7 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.6 | 1.1 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.5 | 1.6 | GO:0016453 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.5 | 18.1 | GO:0044824 | integrase activity(GO:0008907) T/G mismatch-specific endonuclease activity(GO:0043765) retroviral integrase activity(GO:0044823) retroviral 3' processing activity(GO:0044824) |
0.5 | 0.5 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
0.5 | 4.9 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.5 | 27.3 | GO:0008565 | protein transporter activity(GO:0008565) |
0.5 | 1.6 | GO:0089720 | caspase binding(GO:0089720) |
0.5 | 1.6 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.5 | 12.4 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.5 | 2.7 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.5 | 8.6 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.5 | 1.1 | GO:0034809 | enoyl-[acyl-carrier-protein] reductase activity(GO:0016631) 2,3-dihydroxy-2,3-dihydro-phenylpropionate dehydrogenase activity(GO:0018498) cis-2,3-dihydrodiol DDT dehydrogenase activity(GO:0018499) trans-9R,10R-dihydrodiolphenanthrene dehydrogenase activity(GO:0018500) cis-chlorobenzene dihydrodiol dehydrogenase activity(GO:0018501) 2,5-dichloro-2,5-cyclohexadiene-1,4-diol dehydrogenase activity(GO:0018502) trans-1,2-dihydrodiolphenanthrene dehydrogenase activity(GO:0018503) 3,4-dihydroxy-3,4-dihydrofluorene dehydrogenase activity(GO:0034790) benzo(a)pyrene-trans-11,12-dihydrodiol dehydrogenase activity(GO:0034805) benzo(a)pyrene-cis-4,5-dihydrodiol dehydrogenase activity(GO:0034809) citronellyl-CoA dehydrogenase activity(GO:0034824) menthone dehydrogenase activity(GO:0034838) phthalate 3,4-cis-dihydrodiol dehydrogenase activity(GO:0034912) cinnamate reductase activity(GO:0043786) NADPH-dependent curcumin reductase activity(GO:0052849) NADPH-dependent dihydrocurcumin reductase activity(GO:0052850) |
0.5 | 8.1 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.5 | 3.2 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.5 | 0.5 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.5 | 2.1 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.5 | 3.7 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.5 | 2.1 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.5 | 15.8 | GO:0052771 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.5 | 29.5 | GO:0044325 | ion channel binding(GO:0044325) |
0.5 | 14.8 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.5 | 1.6 | GO:0019213 | deacetylase activity(GO:0019213) |
0.5 | 4.7 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.5 | 4.2 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.5 | 33.3 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.5 | 9.9 | GO:0005537 | mannose binding(GO:0005537) |
0.5 | 0.5 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.5 | 2.6 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.5 | 1.0 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.5 | 11.9 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.5 | 0.5 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
0.5 | 6.7 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.5 | 1.5 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.5 | 16.5 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.5 | 2.6 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.5 | 2.5 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.5 | 1.5 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.5 | 3.5 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.5 | 11.0 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.5 | 2.0 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.5 | 1.0 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.5 | 2.5 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.5 | 5.9 | GO:0004629 | phospholipase C activity(GO:0004629) |
0.5 | 6.9 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.5 | 4.4 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.5 | 4.9 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.5 | 1.0 | GO:0070990 | snRNP binding(GO:0070990) |
0.5 | 8.8 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.5 | 0.5 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.5 | 53.0 | GO:0003729 | mRNA binding(GO:0003729) |
0.5 | 1.9 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.5 | 8.7 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.5 | 1.5 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.5 | 2.4 | GO:0035198 | miRNA binding(GO:0035198) |
0.5 | 3.9 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.5 | 2.9 | GO:0009055 | electron carrier activity(GO:0009055) |
0.5 | 4.3 | GO:0015643 | toxic substance binding(GO:0015643) |
0.5 | 2.4 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.5 | 6.6 | GO:0051183 | vitamin transporter activity(GO:0051183) |
0.5 | 2.8 | GO:0034711 | inhibin binding(GO:0034711) |
0.5 | 13.2 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.5 | 1.4 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.5 | 7.4 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.5 | 8.3 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.5 | 6.9 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.5 | 1.4 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.5 | 1.4 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.5 | 5.0 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.5 | 0.9 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.4 | 0.4 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.4 | 5.8 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.4 | 3.1 | GO:0090409 | 3-oxo-2-(2'-pentenyl)cyclopentane-1-octanoic acid CoA ligase activity(GO:0010435) 3-isopropenyl-6-oxoheptanoyl-CoA synthetase activity(GO:0018854) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA synthetase activity(GO:0018855) benzoyl acetate-CoA ligase activity(GO:0018856) 2,4-dichlorobenzoate-CoA ligase activity(GO:0018857) pivalate-CoA ligase activity(GO:0034783) cyclopropanecarboxylate-CoA ligase activity(GO:0034793) adipate-CoA ligase activity(GO:0034796) citronellyl-CoA ligase activity(GO:0034823) mentha-1,3-dione-CoA ligase activity(GO:0034841) thiophene-2-carboxylate-CoA ligase activity(GO:0034842) 2,4,4-trimethylpentanoate-CoA ligase activity(GO:0034865) cis-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034942) trans-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034943) branched-chain acyl-CoA synthetase (ADP-forming) activity(GO:0043759) aryl-CoA synthetase (ADP-forming) activity(GO:0043762) 3-hydroxypropionyl-CoA synthetase activity(GO:0043955) perillic acid:CoA ligase (ADP-forming) activity(GO:0052685) perillic acid:CoA ligase (AMP-forming) activity(GO:0052686) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (ADP-forming) activity(GO:0052687) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (AMP-forming) activity(GO:0052688) pristanate-CoA ligase activity(GO:0070251) malonyl-CoA synthetase activity(GO:0090409) |
0.4 | 1.3 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.4 | 0.9 | GO:0015278 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.4 | 6.6 | GO:0019843 | rRNA binding(GO:0019843) |
0.4 | 2.6 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.4 | 1.3 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.4 | 72.7 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.4 | 2.1 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.4 | 1.3 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.4 | 3.4 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.4 | 1.7 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.4 | 5.4 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.4 | 1.2 | GO:0005536 | glucose binding(GO:0005536) |
0.4 | 0.8 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.4 | 0.8 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.4 | 1.6 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.4 | 6.8 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.4 | 3.6 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.4 | 0.4 | GO:0005290 | L-histidine transmembrane transporter activity(GO:0005290) |
0.4 | 0.4 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.4 | 3.2 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.4 | 1.6 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.4 | 1.6 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.4 | 2.7 | GO:0008237 | metallopeptidase activity(GO:0008237) |
0.4 | 3.5 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.4 | 2.7 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.4 | 1.6 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.4 | 1.2 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.4 | 2.3 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.4 | 1.2 | GO:0015154 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.4 | 3.1 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.4 | 1.9 | GO:0032296 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.4 | 1.1 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.4 | 0.4 | GO:0016937 | short-branched-chain-acyl-CoA dehydrogenase activity(GO:0016937) |
0.4 | 1.5 | GO:0015932 | nucleobase-containing compound transmembrane transporter activity(GO:0015932) |
0.4 | 0.8 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.4 | 0.4 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.4 | 2.6 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.4 | 4.9 | GO:0036442 | hydrogen-exporting ATPase activity(GO:0036442) |
0.4 | 0.4 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.4 | 1.5 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.4 | 1.1 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.4 | 1.5 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.4 | 0.7 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.4 | 3.3 | GO:0030506 | ankyrin binding(GO:0030506) |
0.4 | 1.1 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
0.4 | 2.2 | GO:0031690 | adrenergic receptor binding(GO:0031690) |
0.4 | 1.1 | GO:0015526 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.4 | 1.8 | GO:0043028 | cysteine-type endopeptidase regulator activity involved in apoptotic process(GO:0043028) |
0.4 | 6.8 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
0.4 | 0.7 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.4 | 2.8 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.4 | 23.3 | GO:0016274 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
0.3 | 4.5 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.3 | 0.7 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.3 | 1.0 | GO:0032052 | bile acid binding(GO:0032052) |
0.3 | 0.3 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.3 | 1.0 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.3 | 0.3 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.3 | 2.4 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.3 | 1.7 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.3 | 0.7 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.3 | 3.4 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.3 | 1.7 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.3 | 5.9 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
0.3 | 1.6 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.3 | 7.5 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.3 | 1.3 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.3 | 0.3 | GO:0003916 | DNA topoisomerase activity(GO:0003916) |
0.3 | 2.2 | GO:0016866 | intramolecular transferase activity(GO:0016866) |
0.3 | 0.3 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.3 | 1.0 | GO:0043531 | ADP binding(GO:0043531) |
0.3 | 16.5 | GO:0008186 | ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.3 | 2.2 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.3 | 0.3 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.3 | 4.7 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.3 | 10.0 | GO:0002039 | p53 binding(GO:0002039) |
0.3 | 1.9 | GO:0005522 | profilin binding(GO:0005522) |
0.3 | 1.5 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.3 | 0.3 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.3 | 1.2 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.3 | 13.6 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.3 | 1.5 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.3 | 2.7 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.3 | 14.6 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.3 | 3.9 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.3 | 0.3 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.3 | 1.5 | GO:0071949 | FAD binding(GO:0071949) |
0.3 | 6.2 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.3 | 1.2 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.3 | 0.9 | GO:0031489 | myosin V binding(GO:0031489) |
0.3 | 0.9 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
0.3 | 0.6 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.3 | 6.4 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.3 | 2.9 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.3 | 3.1 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.3 | 2.0 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.3 | 5.1 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.3 | 15.7 | GO:0036459 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.3 | 2.0 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.3 | 0.6 | GO:0048156 | tau protein binding(GO:0048156) |
0.3 | 2.2 | GO:0035250 | UDP-galactosyltransferase activity(GO:0035250) |
0.3 | 0.6 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.3 | 0.3 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.3 | 7.5 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.3 | 2.5 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.3 | 1.1 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.3 | 0.3 | GO:0008061 | chitin binding(GO:0008061) |
0.3 | 0.5 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.3 | 1.4 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.3 | 0.8 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.3 | 4.3 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.3 | 1.9 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.3 | 11.0 | GO:0016779 | nucleotidyltransferase activity(GO:0016779) |
0.3 | 0.8 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
0.3 | 1.3 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.3 | 31.2 | GO:0003924 | GTPase activity(GO:0003924) |
0.3 | 0.8 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.3 | 128.9 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
0.3 | 0.3 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.3 | 2.9 | GO:0004407 | histone deacetylase activity(GO:0004407) |
0.3 | 0.5 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.3 | 5.4 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.3 | 0.3 | GO:0030619 | U1 snRNA binding(GO:0030619) |
0.3 | 0.5 | GO:1990405 | protein antigen binding(GO:1990405) |
0.3 | 0.5 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.3 | 2.3 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.3 | 2.0 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.2 | 1.0 | GO:0005165 | neurotrophin receptor binding(GO:0005165) |
0.2 | 0.5 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.2 | 1.2 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.2 | 0.7 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.2 | 1.0 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.2 | 4.9 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.2 | 1.7 | GO:0080014 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
0.2 | 10.1 | GO:0015171 | amino acid transmembrane transporter activity(GO:0015171) |
0.2 | 0.5 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.2 | 0.5 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.2 | 0.7 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.2 | 11.2 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
0.2 | 4.5 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.2 | 4.3 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.2 | 32.5 | GO:0031625 | ubiquitin protein ligase binding(GO:0031625) |
0.2 | 1.4 | GO:0050700 | CARD domain binding(GO:0050700) |
0.2 | 0.7 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.2 | 4.8 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.2 | 2.8 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.2 | 0.7 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.2 | 2.7 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.2 | 0.2 | GO:0071617 | lysophospholipid acyltransferase activity(GO:0071617) |
0.2 | 0.9 | GO:0016997 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.2 | 4.6 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.2 | 0.9 | GO:0016840 | carbon-nitrogen lyase activity(GO:0016840) |
0.2 | 1.1 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.2 | 0.4 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.2 | 0.7 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
0.2 | 1.7 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.2 | 0.4 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.2 | 0.4 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.2 | 7.0 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.2 | 0.4 | GO:0052743 | inositol tetrakisphosphate phosphatase activity(GO:0052743) |
0.2 | 5.7 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.2 | 0.8 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.2 | 6.3 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.2 | 0.2 | GO:0051540 | iron-sulfur cluster binding(GO:0051536) metal cluster binding(GO:0051540) |
0.2 | 13.2 | GO:0035091 | phosphatidylinositol binding(GO:0035091) |
0.2 | 3.8 | GO:0050699 | WW domain binding(GO:0050699) |
0.2 | 1.0 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.2 | 0.4 | GO:0004359 | glutaminase activity(GO:0004359) |
0.2 | 0.4 | GO:0015215 | nucleotide transmembrane transporter activity(GO:0015215) |
0.2 | 8.5 | GO:0015293 | symporter activity(GO:0015293) |
0.2 | 0.6 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.2 | 1.2 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.2 | 4.7 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.2 | 5.3 | GO:0016209 | antioxidant activity(GO:0016209) |
0.2 | 4.6 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.2 | 0.2 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.2 | 0.8 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.2 | 1.6 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.2 | 0.6 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.2 | 3.4 | GO:0019894 | kinesin binding(GO:0019894) |
0.2 | 2.0 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.2 | 2.0 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.2 | 0.8 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.2 | 3.7 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.2 | 2.4 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.2 | 1.8 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.2 | 2.2 | GO:0016917 | GABA-A receptor activity(GO:0004890) GABA receptor activity(GO:0016917) |
0.2 | 1.1 | GO:0010181 | FMN binding(GO:0010181) |
0.2 | 0.3 | GO:0015925 | galactosidase activity(GO:0015925) |
0.2 | 0.3 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.2 | 1.2 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.2 | 2.9 | GO:0019239 | deaminase activity(GO:0019239) |
0.2 | 0.8 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.2 | 0.8 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.2 | 2.1 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.2 | 0.2 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.2 | 8.6 | GO:0016810 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds(GO:0016810) |
0.2 | 9.4 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.2 | 0.3 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.2 | 0.9 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 0.1 | GO:0036041 | long-chain fatty acid binding(GO:0036041) |
0.1 | 3.1 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.1 | 0.6 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 0.4 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
0.1 | 1.1 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.1 | 30.0 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.1 | 0.4 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.1 | 0.3 | GO:0019862 | IgA binding(GO:0019862) |
0.1 | 1.2 | GO:0001618 | virus receptor activity(GO:0001618) |
0.1 | 2.3 | GO:0043621 | protein self-association(GO:0043621) |
0.1 | 0.4 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.1 | 0.7 | GO:0052745 | inositol phosphate phosphatase activity(GO:0052745) |
0.1 | 0.5 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.1 | 2.8 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
0.1 | 10.5 | GO:0020037 | heme binding(GO:0020037) |
0.1 | 4.8 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.1 | 10.0 | GO:0016798 | hydrolase activity, acting on glycosyl bonds(GO:0016798) |
0.1 | 0.7 | GO:0005231 | excitatory extracellular ligand-gated ion channel activity(GO:0005231) |
0.1 | 0.4 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.1 | 0.9 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.1 | 0.1 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.1 | 2.4 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.1 | 0.6 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) |
0.1 | 8.5 | GO:0016874 | ligase activity(GO:0016874) |
0.1 | 0.2 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.1 | 0.3 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
0.1 | 1.4 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.1 | 1.4 | GO:0019205 | nucleobase-containing compound kinase activity(GO:0019205) |
0.1 | 0.1 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.1 | 0.4 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
0.1 | 0.1 | GO:0046790 | virion binding(GO:0046790) |
0.1 | 0.1 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.1 | 0.5 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.1 | 0.1 | GO:0071813 | lipoprotein particle binding(GO:0071813) protein-lipid complex binding(GO:0071814) |
0.1 | 0.1 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.1 | 0.4 | GO:0004521 | endoribonuclease activity(GO:0004521) |
0.1 | 4.1 | GO:0042277 | peptide binding(GO:0042277) |
0.1 | 0.2 | GO:1990782 | protein tyrosine kinase binding(GO:1990782) |
0.1 | 1.9 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.1 | 1.5 | GO:0008276 | protein methyltransferase activity(GO:0008276) |
0.1 | 0.1 | GO:0033765 | steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) |
0.1 | 0.2 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.1 | 1.3 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.1 | 0.3 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.1 | 0.7 | GO:0048038 | quinone binding(GO:0048038) |
0.1 | 1.1 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.1 | 0.2 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.1 | 0.3 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.1 | 0.3 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.1 | 1.0 | GO:0019956 | chemokine binding(GO:0019956) |
0.1 | 0.1 | GO:0044389 | ubiquitin-like protein ligase binding(GO:0044389) |
0.1 | 4.3 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.1 | 0.1 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 0.2 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.1 | 2.1 | GO:0004620 | phospholipase activity(GO:0004620) |
0.1 | 0.2 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.1 | 0.1 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.1 | 0.8 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.1 | 0.2 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.1 | 0.2 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.1 | 1.0 | GO:0008514 | organic anion transmembrane transporter activity(GO:0008514) |
0.1 | 0.3 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.1 | 0.7 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.1 | 2.2 | GO:0016820 | hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances(GO:0016820) |
0.1 | 0.2 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.1 | 0.1 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
0.1 | 0.1 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.1 | 0.1 | GO:0019767 | IgE receptor activity(GO:0019767) |
0.1 | 0.9 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.1 | 0.2 | GO:0043199 | sulfate binding(GO:0043199) |
0.1 | 1.0 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.1 | 0.1 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.1 | 0.2 | GO:0030345 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.1 | 0.1 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.1 | 0.1 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.1 | 0.1 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.1 | 0.2 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.1 | 0.1 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
0.0 | 1.1 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.0 | 4.7 | GO:0005525 | GTP binding(GO:0005525) |
0.0 | 1.9 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
0.0 | 0.3 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.0 | 0.1 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.0 | 0.0 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
0.0 | 0.0 | GO:0018733 | 3,4-dihydrocoumarin hydrolase activity(GO:0018733) |
0.0 | 0.1 | GO:0031782 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.0 | 0.0 | GO:0031996 | thioesterase binding(GO:0031996) |
0.0 | 0.3 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.0 | 0.3 | GO:0043274 | phospholipase binding(GO:0043274) |
0.0 | 0.2 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.0 | 0.3 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.0 | 0.2 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.0 | 0.1 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.0 | 0.1 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.0 | 0.0 | GO:0019863 | IgE binding(GO:0019863) |
0.0 | 2.4 | GO:0015631 | tubulin binding(GO:0015631) |
0.0 | 0.1 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.0 | 0.2 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.0 | 0.8 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.0 | 0.1 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.0 | 0.1 | GO:0030553 | cGMP binding(GO:0030553) |
0.0 | 0.4 | GO:0016741 | transferase activity, transferring one-carbon groups(GO:0016741) |
0.0 | 5.8 | GO:0004175 | endopeptidase activity(GO:0004175) |
0.0 | 2.5 | GO:0003723 | RNA binding(GO:0003723) |
0.0 | 0.0 | GO:0008142 | oxysterol binding(GO:0008142) |
0.0 | 0.0 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.0 | 0.0 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.0 | 0.0 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.0 | 0.0 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
0.0 | 0.2 | GO:0001848 | complement binding(GO:0001848) |
0.0 | 0.1 | GO:0008081 | phosphoric diester hydrolase activity(GO:0008081) |
0.0 | 0.2 | GO:0016289 | CoA hydrolase activity(GO:0016289) |
0.0 | 0.1 | GO:0042805 | actinin binding(GO:0042805) |
0.0 | 0.0 | GO:0004802 | transketolase activity(GO:0004802) |
0.0 | 0.0 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.4 | 7.3 | ST G ALPHA I PATHWAY | G alpha i Pathway |
1.5 | 45.2 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
1.5 | 35.0 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
1.4 | 33.3 | PID MYC PATHWAY | C-MYC pathway |
1.2 | 1.2 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
1.2 | 35.9 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
1.1 | 6.8 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
1.1 | 20.9 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
1.1 | 30.3 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
1.1 | 5.3 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
1.0 | 1.0 | PID REELIN PATHWAY | Reelin signaling pathway |
1.0 | 8.4 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
1.0 | 2.0 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
1.0 | 1.0 | PID IFNG PATHWAY | IFN-gamma pathway |
1.0 | 4.0 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
1.0 | 17.2 | PID ARF 3PATHWAY | Arf1 pathway |
0.9 | 1.8 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.9 | 9.0 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.9 | 16.9 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.9 | 2.7 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.9 | 3.5 | ST ADRENERGIC | Adrenergic Pathway |
0.8 | 16.8 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.8 | 5.0 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.8 | 7.5 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.8 | 6.5 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.8 | 10.5 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.8 | 5.6 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.8 | 36.0 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.8 | 2.4 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.8 | 19.2 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.7 | 5.2 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.7 | 29.5 | PID PLK1 PATHWAY | PLK1 signaling events |
0.7 | 22.6 | PID CDC42 PATHWAY | CDC42 signaling events |
0.7 | 2.9 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.7 | 5.7 | PID SHP2 PATHWAY | SHP2 signaling |
0.7 | 21.0 | PID AURORA B PATHWAY | Aurora B signaling |
0.7 | 20.2 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.7 | 11.8 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.7 | 6.7 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.7 | 5.4 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.7 | 0.7 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.7 | 1.3 | ST GAQ PATHWAY | G alpha q Pathway |
0.6 | 4.5 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.6 | 7.0 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.6 | 5.1 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.6 | 4.2 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.6 | 5.4 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.6 | 7.1 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.6 | 0.6 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.6 | 15.7 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.6 | 5.2 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.6 | 1.7 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.6 | 2.8 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.6 | 9.5 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.6 | 18.3 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.5 | 12.6 | PID ATR PATHWAY | ATR signaling pathway |
0.5 | 1.1 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.5 | 0.5 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.5 | 4.1 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.5 | 2.5 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.5 | 11.6 | PID BARD1 PATHWAY | BARD1 signaling events |
0.5 | 2.4 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.5 | 6.1 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.5 | 3.8 | PID AURORA A PATHWAY | Aurora A signaling |
0.5 | 8.4 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.4 | 2.2 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.4 | 13.9 | PID LKB1 PATHWAY | LKB1 signaling events |
0.4 | 1.8 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.4 | 0.9 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.4 | 5.6 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.4 | 6.8 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.4 | 8.8 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.4 | 4.6 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.4 | 0.4 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.4 | 11.7 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.4 | 5.1 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.4 | 0.7 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.4 | 0.7 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.3 | 1.0 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.3 | 5.1 | PID RHOA PATHWAY | RhoA signaling pathway |
0.3 | 4.0 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.3 | 4.9 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.3 | 4.8 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.3 | 10.3 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.3 | 3.7 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.3 | 0.9 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.3 | 0.6 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.3 | 2.9 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.3 | 6.9 | PID P53 REGULATION PATHWAY | p53 pathway |
0.3 | 7.5 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.3 | 5.0 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.3 | 5.0 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.3 | 0.8 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.2 | 1.2 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.2 | 0.7 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.2 | 6.7 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.2 | 3.9 | PID FOXO PATHWAY | FoxO family signaling |
0.2 | 2.6 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.2 | 1.5 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.2 | 0.6 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.2 | 0.4 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.2 | 2.4 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.2 | 1.8 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.2 | 1.3 | PID ARF6 PATHWAY | Arf6 signaling events |
0.2 | 0.8 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.1 | 1.7 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 0.2 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.1 | 0.4 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.1 | 0.1 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.1 | 1.0 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 0.4 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.1 | 2.4 | PID E2F PATHWAY | E2F transcription factor network |
0.0 | 0.8 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.0 | 0.1 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.0 | 1.3 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.0 | 0.0 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 0.0 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.0 | 0.6 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.1 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.8 | 3.8 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
2.4 | 2.4 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
2.4 | 7.2 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
2.2 | 8.7 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
2.1 | 8.2 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
2.0 | 10.0 | REACTOME SIGNALLING BY NGF | Genes involved in Signalling by NGF |
2.0 | 31.9 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
1.9 | 27.0 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
1.9 | 27.0 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
1.9 | 15.0 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
1.9 | 20.4 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
1.8 | 24.8 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
1.8 | 8.8 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
1.7 | 18.8 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
1.7 | 16.7 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
1.6 | 34.0 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
1.6 | 15.8 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
1.6 | 3.1 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
1.6 | 31.3 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
1.5 | 3.0 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
1.5 | 16.2 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
1.5 | 20.3 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
1.4 | 24.6 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
1.4 | 70.7 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
1.4 | 10.1 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
1.4 | 4.3 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
1.4 | 14.2 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
1.4 | 8.3 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
1.4 | 13.7 | REACTOME SIGNALING BY WNT | Genes involved in Signaling by Wnt |
1.4 | 16.4 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
1.4 | 15.0 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
1.3 | 5.4 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
1.3 | 21.5 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
1.3 | 14.7 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
1.3 | 23.3 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
1.3 | 18.1 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
1.3 | 1.3 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
1.3 | 17.7 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
1.3 | 8.8 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
1.2 | 8.7 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
1.2 | 5.0 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
1.2 | 6.2 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
1.2 | 1.2 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
1.2 | 12.2 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
1.2 | 3.6 | REACTOME GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK | Genes involved in Gastrin-CREB signalling pathway via PKC and MAPK |
1.2 | 2.4 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
1.2 | 43.0 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
1.2 | 13.1 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
1.2 | 10.5 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
1.2 | 2.3 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
1.2 | 16.2 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
1.1 | 13.5 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
1.1 | 11.0 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
1.1 | 11.0 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
1.1 | 11.9 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
1.1 | 3.2 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
1.1 | 31.1 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
1.1 | 14.8 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
1.0 | 4.1 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
1.0 | 6.1 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
1.0 | 16.4 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
1.0 | 8.2 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
1.0 | 11.1 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
1.0 | 8.1 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
1.0 | 1.0 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
1.0 | 6.0 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
1.0 | 14.0 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
1.0 | 10.9 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
1.0 | 7.8 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
1.0 | 14.4 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.9 | 24.6 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.9 | 2.8 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.9 | 9.2 | REACTOME SHC RELATED EVENTS | Genes involved in SHC-related events |
0.9 | 0.9 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
0.9 | 2.7 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.9 | 19.7 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.9 | 23.6 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.9 | 14.8 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.9 | 35.6 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.9 | 9.5 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.9 | 22.3 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.9 | 11.1 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.9 | 3.4 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.8 | 9.2 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.8 | 7.4 | REACTOME CDT1 ASSOCIATION WITH THE CDC6 ORC ORIGIN COMPLEX | Genes involved in CDT1 association with the CDC6:ORC:origin complex |
0.8 | 9.9 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.8 | 17.8 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.8 | 1.6 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.8 | 8.1 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.8 | 4.8 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
0.8 | 2.4 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
0.8 | 31.7 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.8 | 20.6 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.8 | 1.6 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.8 | 11.0 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.8 | 7.7 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.8 | 12.2 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.7 | 7.4 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.7 | 12.6 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.7 | 1.5 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.7 | 6.6 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.7 | 8.8 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.7 | 17.5 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.7 | 5.1 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.7 | 9.4 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.7 | 2.1 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.7 | 11.9 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.7 | 22.0 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.7 | 31.5 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.7 | 6.9 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.7 | 2.7 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.7 | 3.4 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.7 | 8.8 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.7 | 6.7 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.7 | 6.7 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.7 | 5.3 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.7 | 15.1 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.6 | 6.5 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.6 | 4.5 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.6 | 3.8 | REACTOME NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Neurotransmitter Release Cycle |
0.6 | 10.8 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.6 | 0.6 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.6 | 11.4 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.6 | 14.3 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.6 | 11.9 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.6 | 1.8 | REACTOME OPIOID SIGNALLING | Genes involved in Opioid Signalling |
0.6 | 5.2 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.6 | 4.1 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.6 | 4.6 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.6 | 16.1 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.6 | 5.2 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.6 | 6.3 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.6 | 2.8 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.6 | 13.0 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.6 | 31.9 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.6 | 9.4 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.5 | 5.4 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.5 | 6.9 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.5 | 8.4 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.5 | 2.6 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.5 | 6.3 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.5 | 16.0 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.5 | 1.0 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.5 | 65.2 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.5 | 3.0 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.5 | 21.9 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.5 | 8.9 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.5 | 1.5 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.5 | 8.8 | REACTOME TRANSMISSION ACROSS CHEMICAL SYNAPSES | Genes involved in Transmission across Chemical Synapses |
0.5 | 4.9 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.5 | 7.8 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
0.5 | 1.4 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.5 | 21.9 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.5 | 9.4 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.5 | 1.4 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.5 | 54.1 | REACTOME TRANSLATION | Genes involved in Translation |
0.5 | 2.3 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.5 | 8.2 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.5 | 5.0 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.4 | 3.1 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.4 | 10.7 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.4 | 1.8 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.4 | 1.8 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.4 | 4.8 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.4 | 11.4 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.4 | 6.0 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.4 | 1.3 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.4 | 1.7 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.4 | 6.9 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.4 | 3.1 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.4 | 3.7 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.4 | 0.4 | REACTOME S PHASE | Genes involved in S Phase |
0.4 | 2.9 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.4 | 6.5 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.4 | 1.8 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.4 | 8.2 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.4 | 3.9 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.3 | 2.8 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.3 | 2.8 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
0.3 | 8.1 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.3 | 21.7 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.3 | 3.6 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.3 | 14.2 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.3 | 2.6 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.3 | 1.6 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.3 | 2.2 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.3 | 2.0 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.3 | 1.4 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.3 | 3.0 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.3 | 5.0 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.3 | 1.9 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.3 | 1.9 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.3 | 1.8 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.3 | 4.5 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.2 | 1.2 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.2 | 0.2 | REACTOME FORMATION OF THE HIV1 EARLY ELONGATION COMPLEX | Genes involved in Formation of the HIV-1 Early Elongation Complex |
0.2 | 1.0 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.2 | 3.3 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.2 | 4.0 | REACTOME PI METABOLISM | Genes involved in PI Metabolism |
0.2 | 3.2 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.2 | 4.5 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.2 | 8.2 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.2 | 2.4 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.2 | 0.9 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.2 | 0.6 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.2 | 1.3 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.2 | 2.9 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.2 | 1.0 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.2 | 2.1 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
0.2 | 1.7 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.2 | 1.1 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.2 | 1.1 | REACTOME ION CHANNEL TRANSPORT | Genes involved in Ion channel transport |
0.2 | 0.2 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.2 | 0.5 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.2 | 2.7 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.2 | 1.0 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.2 | 1.3 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.2 | 2.6 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.2 | 5.0 | REACTOME APOPTOTIC EXECUTION PHASE | Genes involved in Apoptotic execution phase |
0.2 | 2.2 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.1 | 7.3 | REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
0.1 | 1.5 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.1 | 2.8 | REACTOME PROTEIN FOLDING | Genes involved in Protein folding |
0.1 | 0.7 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.1 | 2.2 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 9.7 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.1 | 5.1 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.1 | 2.2 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.1 | 1.2 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 0.6 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.1 | 0.8 | REACTOME METABOLISM OF PROTEINS | Genes involved in Metabolism of proteins |
0.1 | 0.5 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.1 | 0.6 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.1 | 1.2 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.1 | 0.8 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.1 | 12.9 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.1 | 3.3 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 0.2 | REACTOME GAB1 SIGNALOSOME | Genes involved in GAB1 signalosome |
0.1 | 0.2 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.1 | 1.8 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 0.1 | REACTOME REGULATION OF MITOTIC CELL CYCLE | Genes involved in Regulation of mitotic cell cycle |
0.1 | 0.2 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 0.4 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.1 | 0.6 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.1 | 0.4 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 0.1 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.1 | 0.2 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
0.1 | 0.9 | REACTOME SIGNALING BY TGF BETA RECEPTOR COMPLEX | Genes involved in Signaling by TGF-beta Receptor Complex |
0.0 | 0.4 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 1.7 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.0 | 0.2 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.0 | 0.1 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.0 | 0.1 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.0 | 0.2 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.0 | 0.1 | REACTOME TRANSPORT OF GLUCOSE AND OTHER SUGARS BILE SALTS AND ORGANIC ACIDS METAL IONS AND AMINE COMPOUNDS | Genes involved in Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds |
0.0 | 0.1 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.0 | 0.1 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.0 | 0.3 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.0 | 0.2 | REACTOME TCR SIGNALING | Genes involved in TCR signaling |
0.0 | 0.1 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.0 | 0.1 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.0 | 0.1 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |